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Abstract
Joint Modeling of Mixed Outcomes in Clinical Research
by
Yuqi Chen
Mixed types of multivariate outcomes are common in clinical investigations. Survival
time is one of the primary goals in practice. In addition, hospitalization attracts increas-
ing attention as it is a main contributor to the total cost of care, and the identification
of related risk factors is of interest in many health economics studies. Meanwhile, we
are also interested in the longitudinal path of important clinical measurements along the
progress of disease. Joint modeling is often required as both hospitalization frequencies
or longitudinal measurements can be informatively censored due to death. In this dis-
sertation, we will propose three research projects which jointly model multiple aspects
of the outcomes.
The first research project models survival time and hospitalization together through
a latent subject-specific random frailty. B-spline bases are introduced for flexible forms
of baseline hazard and the offset function. Computational methods to solve for the
MLE and to select knots are developed. The proposed methods are applied to study the
risk factors of hospitalization and survival time among end-stage-renal-disease (ESRD)
patients.
The second part proposes a joint model of hospitalization and readmission. Number
of hospitalizations is modeled as a Poisson random variable and number of readmissions
is treated as a Binomial random variable with number of hospitalizations being the
total number of trials. The proposed joint modeling framework is applied to evaluate the
performance of an intervention program from Fresenius Medical Care in reducing number
vii
of hospitalizations and readmissions.
The third research project jointly models survival time and multiple longitudinal
observations. A penalized likelihood approach is described for variable selection. We
design a Coordinate Descent Algorithm to solve for the penalized MLE and a two-stage
estimation method to reduce the bias resulting from penalization. Simulation results
demonstrate good selection and estimation property. We illustrate the practical usage of
proposed method through an application to ESRD patients.
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Chapter 1
Introduction
Mixed types of outcomes are very common in clinical research. Patients’ survival time
is often the primary interest. Other outcomes of interest include hospitalization, quality
of life and important clinical measurements. The main interest is to investigate the
relationship between mixed outcomes and predictors. The study may be cross-sectional
where predictors are observed at baseline and outcomes are observed at follow-up time,
or longitudinal where both outcomes and predictors are observed over time. Outcomes
collected from the same patient are usually correlated since they reflect the patient’s
underlying health condition. Therefore fitting each outcome separately is less efficient
compared with joint modeling, and may lead to bias. For example, Ibrahim et al. [32] and
Henderson et al. [27] have shown that severe bias occurs for some parameters when latent
association between longitudinal measures and event time data is ignored. Liu et al. [40]
have also shown that ignoring the dependence between the terminal and recurrent events
can result in significant biases. Statistical techniques of joint modeling are required for
valid data analysis and inference.
Our research is motivated by the need for improvement in care for patients who have
end-stage renal disease (ESRD). Chronic kidney disease (CKD) is a major public health
1
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problem affecting 11% of the US population [8]. ESRD is the last stage of CKD when
kidneys can no longer support the body’s needs. ESRD patients need kidney transplants
or rely on dialysis to remove extra salt, water, and waste products. ESRD is a complex
condition, the failure of kidney function is accompanied by numerous metabolic changes
which affect almost all organ systems of the human body. In general, ESRD patients
suffer from multiple comorbidities, such as diabetes and cardiovascular diseases, resulting
in frequent hospitalizations and substantial mortality. Many scientific questions arise in
practice in the care for ESRD patients that require novel statistical methodologies. This
dissertation aims to develop efficient and valid statistical methodologies to address these
scientific questions.
We will develop statistical methods for three situations with mixed outcomes and
apply them to investigate the relationships between mortality, hospitalization and pre-
dictors. We introduce these three situations in the next three sections.
1.1 Joint Modeling of Mortality and Hospitalization
with Cross-Sectional Data
Hospitalization, an important marker of disease severity, and a substantial contributor
to medical cost, has attracted much attention in the literature. The aggregated cost for
all hospital stays was $387.3 billion in 2011, nearly one-third of all health care expenses in
the United States [44]. Specifically, the aggregate cost for stays with acute and unspecified
renal failure jumped from $1.0 billion in 1997 to $4.7 billion in 2011.
The high stake of hospitalization motivates health care professionals and policy mak-
ers to investigate associated risk factors for better intervention. A large number of studies
have studied the risk factors for various diseases. For example, Moss et al. [43] identified
2
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risk factors for hospitalization in diabetic patients, Eisner et al. [13] studied the risk
factors for hospitalization among adult asthma patients, Dennehy et al. [11] investigated
risk factors for hospitalization in pediatric rotavirus gastroenteritis patients. Inrig et al.
[34] and Brotman et al. [3] examined the effects of blood pressure changes and heart rate
variability on hospitalization in ESRD patients respectively.
One challenge in modeling hospitalization is that it is informatively censored by a
terminal event, namely death. Therefore it is desirable to model the two outcomes
(death and hospitalization) jointly since they are correlated. To investigate risk factors
associated with mortality and hospitalization together, in Chapter 2 I will propose a semi-
parametric joint model for survival time and a random variable from exponential family.
Hospitalization can be easily fitted into this framework. For example, the number of
hospitalizations can be treated as Poisson random variables and the total length of stay,
another important measure of hospitalization, can be modeled by Gamma distribution.
Shared frailty is introduced to account for the correlation between the two outcomes. An
offset function is incorporated in the hospitalization sub-model to accommodate the fact
that hospitalization can only be observed prior to death. To allow flexible form of baseline
hazard and the offset set, I assume each of these is a smooth function and model them
using B-splines with the number of knots selected by the AIC criterion. A method for
computing the maximum likelihood estimates will be developed and implemented using
SAS Proc NLMIXED. Simulations will be conducted to evaluate the proposed method. I
apply the proposed method to study the risk factors for hospitalization and mortality of
ESRD patients who are on hemodialysis. I analyze two applications on ESRD patients:
joint model of frequency of hospitalization and survival time, and joint model of total
length of stays and survival time.
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1.2 Joint Modeling of Hospitalization and Readmis-
sion
Readmission is defined as a patient being admitted to a hospital within a certain time
period from an initial admission. A 30-days rule is usually used by Medicare. A study of
Medicare claims data from 2003 to 2004 found that almost one fifth (19.6%) of Medicare
beneficiaries who had been discharged from a hospital were rehospitalized within 30 days
[35]. The estimated cost to Medicare of unplanned rehospitalization in 2004 was as high
as $17.4 billion.
If a hospital has a high proportion of patients readmitted within a short time frame,
it may be an indication of inadequate quality of care in the hospital or a lack of appro-
priate coordination of post-discharge care. Preventable hospital readmissions result from
several factors: lack of discharge instruction, poor quality post-hospitalization care or
poor transition of patients among providers. Many efforts have been made to alleviate
these problems [23].
Hospitalization cost and readmission rates are high in ESRD patients. United States
Renal Data System reports that in 2015, hospitalization accounts for approximately 40%
of total Medicare expenditures for dialysis patients and about 30% of ESRD patients
have an unplanned rehospitalization within the 30 days following discharge [50].
Targeting on ESRD patients on hemodialysis, Fresenius Medical Care initiated an
intervention program in 2013 in order to reduce the number of hospitalizations and read-
missions for ESRD patients on hemodialysis. Details about this study will be discussed
in Chapter 3.
Motivated by the need of evaluation for this intervention program, I propose a joint
model for hospitalization and readmission in Chapter 3. The number of hospitalizations is
modeled using a Poisson distribution, and conditional on the number of hospitalizations,
4
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the number of readmissions is modeled using a Binomial distribution where the number
of hospitalizations serves as the total number of trials. A shared frailty term is intro-
duced and an extra function is incorporated to explain the possible non-linear association
between the two responses. I apply the proposed method to evaluate the effectiveness of
the intervention program in reducing patients hospitalizations and readmissions.
1.3 Variable Selection in Joint Modeling of Multi-
variate Longitudinal Covariates and Survival Time
Methods in the previous two sections are intended for cross sectional data, where a
baseline period and a follow-up period are established. This section considers longitudinal
studies. The important clinical measurements are recorded repeatedly over time and
the longitudinal patterns provide insights of disease progression. In some situations,
the course of a disease is determined by one underlying clinical measurement which is
referred as a biomarker. For example, for HIV patients, CD4 cell counts is a well known
biomarker and is often monitored longitudinally together with patients’ survival time. In
some other complicated diseases, no one golden biomarker exists and therefore multiple
longitudinal processes need to be recorded. For example in ESRD patients, the impaired
kidney function is accompanied by numerous biological changes in the body and there is
no one simple clinical measurement that fully captures the disease progression.
Since the longitudinal processes are correlated and terminated by patients’ death,
a large body of literatures have explored joint modeling of longitudinal processes and
survival time [62, 9, 17, 56, 31]. Mixed effects models are commonly used to model the
longitudinal covariate and the Cox proportional hazard model is a classical choice for
survival time. Shared random effects are often introduced to account for the correlation
5
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between the two outcomes. Joint modeling of multiple longitudinal processes and survival
time has also been proposed from a Bayesian’s perspective [4]. However variable selection,
an essential part in statistical theory and practice, is rarely discussed in the literature
of joint modeling framework. Variable selection is especially important when there are
multiple longitudinal outcomes.
To fill this gap, I will propose a joint model for multiple longitudinal outcomes and
survival time in Chapter 4. Longitudinal outcomes are modeled by multivariate linear
mixed effect models. The random intercepts and slopes, as trajectories of longitudinal
measurements, are then incorporated in the sub-model of survival time. A penalized
likelihood approach is proposed to perform variable selection of these random effects
in a Cox model. I will develop a coordinate descent algorithm for the optimization
of penalized likelihood. A two-stage estimation method will be adopted to reduce the
estimation biases resulting from penalization. The proposed procedure will be applied to
an ESRD study to identify important predictors for mortality.
6
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Joint Modeling of Mortality and
Hospitalization with Cross-Sectional
Data
2.1 Introduction and Related Work
Hospitalization is a main contributor to the total cost of care, and identification of
the related risk factors is of interest in many health care studies. The main difficulty
in modeling hospitalization data is due to the fact that the frequency of hospitaliza-
tion and the total length of hospital stays are functions of follow-up time that can be
informatively censored due to death. Since both the hospitalization outcome and time-
to-death are related to the underlying health, it is desirable to jointly model them as
bivariate outcomes. Mixed types of multivariate outcomes are common in many fields of
science and social science. Various statistical models and methods have been proposed
to deal with different types of mixed outcomes [10]. For example, Fitzmaurice and Laird
proposed regression models for continuous and binary outcomes [18], Sammel et al. pro-
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posed latent variable models for mixed discrete and continuous outcomes [49], Catalano
proposed a latent variable model for continuous and ordinal outcomes [6], and Dunson
and Herring proposed Bayesian latent variable models for mixed outcomes [12]. These
methods can not handle censored data which is needed for joint modeling of survival time
and hospitalization in health studies.
A large number of models have been developed aiming at the joint modeling of survival
hazard function and hospitalization rate simultaneously. For example, Lancaster and
Intrator 1998 [37], Wang, Qin and Chiang 2001 [60], Huang and Wang 2004 [30], Liu,
Wolfe and Huang 2004 [40], Huang, Qin and Wang 2010 [29] and the references therein.
These researches treat hospitalization as a recurrent event and death as a terminal event.
And they are interested in modeling the intensity function of the recurrent process. In
this research, we are interest in modeling the expected number of hospital admissions
and hospital stay.
Our research is motivated by the need for improvement in care for end-stage renal
disease (ESRD) patients. Hemodialysis (HD) is the most frequently used treatment
modality for ESRD patients. In general, HD patients suffer from multiple comorbidi-
ties, such as diabetes and cardiovascular diseases, resulting in frequent hospitalizations
and substantial mortality. In spite of improvements over the years, hospitalization and
mortality rates of ESRD patients on HD remain much higher than those of the general
population [7]. In this chapter I am interested in identifying risk factors for hospital-
ization and mortality. The data come from an observational study of patients on HD
in Fresenius Medical Care. Covariates at baseline and outcomes including survival time,
hospital admissions and total length of hospital stay at follow-up were collected. Ap-
proximately 20% of patients died during the follow-up period and observational times for
hospitalization outcomes of these patients are censored due to death. Since both survival
time and hospitalization are associated with the underlying health condition, it is likely
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that these outcomes from the same subject are correlated. Therefore, it is necessary to
develop a joint model for survival time and hospitalization. Details of the data are given
in Section 2.5.
In this chapter I propose a semi-parametric latent variable model for joint modeling
of a survival time and an outcome from exponential family. The survival time is modeled
by a semi-parametric proportional hazard model with a subject-specific random effect.
The hospitalization related endpoint, such as the number of admissions, length of stay or
whether a subject has ever been hospitalized, can be model by a generalized linear mixed
effects model. Since the hospitalization outcome may only be observed before death,
an offset function will be included in the generalized linear model to take into account
the follow-up time. To allow a flexible relationship between the hospitalization endpoint
and the follow-up time, I introduce a nonparametric smooth offset function that includes
parametric functions, such as logarithm, as special cases. When the offset function is
parametric, these models reduce to the standard generalized mixed effects models and
parameters of interest may be interpreted in terms of the constant conditional means
such as incident rate, mean duration and average probability. The smooth offset function
allows deviation from this rigid assumption. The forms of the baseline hazard function
and the offset function are usually unknown. They will be modeled non-parametrically
using spline functions with non-negative and, when appropriate, monotone constraints.
A latent random variable will be used to model potential correlation between survival
time and hospitalization outcome from the same subject [42]. I will further discuss the
estimation procedures which can be conveniently carried out using existing softwares.
The rest of this chapter is organized as follows. Section 2.2 introduces the semi-
parametric latent variable model. Section 2.3 provides details about our estimation
procedure. Sections 2.4 and 2.5 present simulation results and applications to patients
on HD. The chapter ends with a discussion in Section 2.6.
9
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2.2 The Semi-parametric Latent Variable Model
2.2.1 The Overall Model
For subject i, I denoteDi as the death time, Ci as the censoring time, Ti = min{Ci, Di}
as the observed time, ∆i = I(Di < Ci) as the event indicator and hi(t) as the hazard
function. Let Yi be another outcome variable from exponential family. Let Z
D
i and Z
Y
i
be covariates associated with the outcomes Di and Yi respectively. Note that Z
Y
i may
include ∆i. We will consider the following joint model:
hi(t) = h0(t) exp(β
′ZDi + νi),
g (E(Yi|Ti, νi)) = w(Ti) + α′ZYi + ηνi,
(2.1)
where h0(t) is the baseline hazard, g is the link function, νi
iid∼ N(0, σ2) is a shared frailty
for subject i, and w is an offset function. The first equation in (2.2) is a Cox proportional
hazard model for survival time while the second equation in (2.2) is a generalized linear
model for Yi. The shared frailty is introduced to model heterogeneity among subjects
and correlation between Di and Yi within a subject. The distribution of the shared
frailty is assumed to be normal for simplicity. Extensions to other distributions are
straightforward. The offset term w(Ti) is introduced to account for the fact that Yi is
only observed prior to time Ti.
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2.2.2 A Spline Model for the Baseline Hazard
The form of the baseline hazard function h0(t) is generally unknown in practice. We
will assume that h0(t) is a smooth function and model it using B-spline basis functions:
h0(t) =
K+1+Lh∑
k=1
dkBk(t|K1, τh),
where Bk(t|K, τh) denotes the evaluation at t of the K-degree B-spline basis functions
generated with interior knots τh = {th1, th2, · · · , thLh}. We will use the constraints dk ≥ 0
to enforce the non-negativity constraint of the function h0(t). The function h0(t) is
decided by coefficients dk as well as the number and locations of knots. The estimation
of coefficients and the selection of knots will be discussed in Section 2.3.
2.2.3 A Spline or Monotone Spline Model for the Offset Func-
tion
When Yi represents counts such as hospital admissions, one possible assumption is
that Yi is generated from a homogeneous Poisson process. Under this assumption and
canonical link for Poisson data, the offset function w(t) = log(t). However in practice Yi
may be generated from a non-homogeneous Poisson process [59]. It is therefore desirable
to leave the functional form of w unspecified. Again I model w nonparametrically using
B-spline basis functions:
w(t) =
K+1+Lw∑
k=1
ckBk(t|K, τw),
where Bk(t|K, τw) denotes the evaluation at t of the K-degree B-spline basis functions
generated with internal knots τw = {tw1, tw2, · · · , twLw}.
For Poisson data, it is natural to assume that the expectation of Yi increases with
the observational time Ti. In this case I assume that w(t) is a smooth non-decreasing
11
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function. Ramsay used integrated M -splines to fit a monotone spline [47]. We will adopt
a similar approach using integrated B-splines. Specifically, denote integrated B-splines
as Ik(t|K, τ) =
∫ t
0
Bk(u|K, τ)du for k = 1, . . . , K. Since Bk’s are non-negative, then Ik’s
provide a set of non-decreasing basis functions. We model w using integrated B-spline
basis functions:
w(t) =
K+1+Lw∑
k=1
ckIk(t|K, τw) + c,
where c is an unknown constant and ck’s are coefficients with constraints ck ≥ 0.
2.3 Estimation Method
The full likelihood is
L =
n∏
i=1
∫
f(Yi|Ti,∆i, νi)li(Ti,∆i|νi)fν(νi)dνi, (2.2)
where n is the total number of subject, f(Yi|Ti,∆i, νi) is the conditional density of Yi in
the exponential family, fν(νi) is the density function of the latent random variable ν, and
li(Ti,∆i|νi) =
{
h0(Ti) exp(β
′ZDi + νi)
}∆i
exp
{
−
∫ Ti
0
h0(t) exp(β
′ZDi + νi)dt
}
.
Our goal is then to obtain parameter estimates by maximizing the likelihood. Since
there is no closed form solution, I apply the Newton-Raphson methods to compute param-
eter estimates numerically. For stability, I apply the Newton-Raphson ridge optimization
where a pure Newton step is used when the Hessian is positive definite and when the
Newton step successfully increases the value of the likelihood, otherwise a multiple of the
identity matrix is added to the Hessian matrix [38]. To calculate the gradient and Hessian
matrix, I need to evaluate integrals derived from the likelihood function. The Gaussian
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quadrature method is used to approximate these integrals. We estimate random effects
νi by their empirical Bayes estimators νˆi that maximize f(yi|Ti,∆i, νi)li(Ti,∆i|νi)fν(νi).
Numerically stable implementations of these methods can be obtained from a variety
of publicly available softwares [46]. In our simulation and example, I employed SAS
procedure Proc NLMIXED to perform the computation. Proc NLMIXED has an appealing
feature which allows a user-specified log likelihood functions with respect to the random
effects. See [38] for details on this procedure.
The number and location of knots are fixed in the above discussion. While increasing
the number of knots has the capability to model a more flexible function, having too many
knots will increase the complexity of the model and result in over-fitting. A data-driven
procedure for the selection of number and location of knots is desirable. We allow h0(t)
and w(t) to have different numbers and locations of knots. In practice one may place
knots evenly in a range or at equally spaced quantiles of data. We select the numbers of
knots by minimizing the following AIC [1]:
AIC(Lh, Lw) = −2 logL+ 2(Lh + Lw + 2K + 2), (2.3)
where Lh and Lw are the number of knots for baseline hazard function and offset function
respectively.
2.4 Simulations
We generate simulation samples from the following model
hi(t|νi) = h0(t) exp(βZi + νi),
log(E(Yi|Ti, νi)) = w(Ti) + αZi + ηνi,
(2.4)
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where Zi’s are iid random variables with P (Zi = 0) = P (Zi = 1) = 0.5, νi
iid∼ N(0, 0.5),
and conditional on Ti and νi, Yi follows a Poisson distribution with mean exp(w(Ti)+αZi+
ηνi). The censoring time Ci = min{Ei, 4} where Ei iid∼ Exp(0.1). The true parameters are
set to be (α, β, η) = (0.5, 0.5, 1). We consider two baseline hazard functions, Exponential
baseline h0(t) = 1/2 and Weibull baseline h0(t) = t/2, and two offset functions, linear
function w(t) = t/2 and log function w(t) = log(t).
The baseline hazard h0(t) is estimated using cubic B-spline basis functions. The
offset function w(t) is estimated using cubic integrated B-spline basis functions under
the monotone constraint. Interior knots are equally spaced within the time period (0, 4],
and the number of knots for h0(t) and w(t) range from 2 to 4 respectively. The optimal
combination of number of knots is selected by minimizing the AIC (2.3).
Simulation under each setting is repeated 500 times. For the estimation of parameters,
I compute bias, mean squared error (MSE) and coverage probability of 95% confidence
intervals (CP). The 95% confidence interval is constructed as the MLE plus-minus 1.96
times the standard errors obtained from the variance-covariance matrix. For the estima-
tion of functions h0(t) and w(t), I compute the integrated mean square error (IMSE)
IMSE(fˆ) =
∫ 4
0
(fˆ(t)− f(t))2dt
for each replicate, where f is either h0 or w.
Tables 2.1, 2.2, 2.3, 2.4, 2.5 summarize performances of parameter and function es-
timates under four simulation settings. Overall the proposed estimation procedure per-
forms well: bias and MSE are small, and the coverages of 95% confidence intervals are
close to the nominal value. The performances improve as sample size increases.
As an illustration, Figure 2.1 shows the 5th, 25th, 50th, 75th and 95th best estimates
of hˆ0(t) and wˆ(t) ordered by the IMSE under the simulation setting when h0(t) = t/2,
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Table 2.1: Bias, mean squared error (MSE) and coverage probability of 95% confidence
intervals (CP) based on the joint model when h0(t) = 1/2 and w(t) = t/2.
h0(t) = 1/2 w(t) = t/2 α β η σ
2
n = 300 Bias 0.007 0.045 -0.064 0.337
MSE 0.017 0.037 0.066 0.65
CP 0.938 0.981 0.809 0.965
n = 500 Bias 0.002 0.014 -0.008 0.149
MSE 0.010 0.022 0.871 0.936
CP 0.946 0.946 0.871 0.936
n = 1000 Bias 0.002 0.008 0.003 0.063
MSE 0.005 0.01 0.031 0.062
CP 0.94 0.948 0.916 0.94
Table 2.2: Bias, mean squared error (MSE) and coverage probability of 95% confidence
intervals (CP) based on the joint model when h0(t) = 1/2 and w(t) = log(t).
h0(t) = 1/2 w(t) = log(t) α β η σ
2
n = 300 Bias 0.033 0.084 -0.106 0.779
MSE 0.025 0.064 0.109 2.833
CP 0.966 0.968 0.774 0.957
n = 500 Bias 0.016 0.046 -0.03 0.381
MSE 0.016 0.030 0.088 0.912
CP 0.955 0.973 0.842 0.953
n = 1000 Bias 0.004 0.017 0.005 0.127
MSE 0.007 0.011 0.053 0.156
CP 0.947 0.966 0.890 0.951
Table 2.3: Bias, mean squared error (MSE) and coverage probability of 95% confidence
intervals (CP) based on the joint model when h0(t) = t/2 and w(t) = t/2.
h0(t) = t/2 w(t) = t/2 α β η σ
2
n = 300 Bias -0.003 0.008 0.016 0.056
MSE 0.011 0.025 0.06 0.075
CP 0.968 0.963 0.925 0.951
n = 500 Bias -0.006 0.008 0.007 0.044
MSE 0.007 0.015 0.038 0.052
CP 0.944 0.962 0.912 0.930
n = 1000 Bias -0.002 0.003 0.011 0.017
MSE 0.003 0.008 0.022 0.025
CP 0.950 0.946 0.942 0.928
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Table 2.4: Bias, mean squared error (MSE) and coverage probability of 95% confidence
intervals (CP) based on the joint model when h0(t) = t/2 and w(t) = log(t).
h0(t) = t/2 w(t) = log(t) α β η σ
2
n = 300 Bias 0.033 0.064 -0.025 0.346
MSE 0.020 0.064 -0.025 0.346
CP 0.958 0.973 0.859 0.936
n = 500 Bias 0.014 0.036 -0.014 0.227
MSE 0.013 0.027 0.070 0.386
CP 0.945 0.955 0.850 0.951
n = 1000 Bias 0.009 0.015 -0.009 0.117
MSE 0.006 0.011 0.040 0.100
CP 0.954 0.950 0.892 0.942
Table 2.5: Integrated Mean Square Error (IMSE) of the baseline hazard h0(t) and
offset function w(t) fitted by the joint model.
h0(t) w(t)
h0(t) = 1/2 n = 300 0.078 0.079
w(t) = t/2 n = 500 0.050 0.052
n = 1000 0.027 0.027
h0(t) = 1/2 n = 300 0.109 0.151
w(t) = log(t) n = 500 0.063 0.097
n = 1000 0.033 0.052
h0(t) = t/2 n = 300 0.665 0.066
w(t) = t/2 n = 500 0.456 0.043
n = 1000 0.230 0.025
h0(t) = t/2 n = 300 0.856 0.165
w(t) = log(t) n = 500 0.662 0.114
n = 1000 0.340 0.057
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w(t) = log(t) and n = 500. Overall, the estimates are close to the true functions except
for the baseline hazard with large t. The poor estimation of the baseline hazard with
large t is likely caused by censoring. Estimation performance of hˆ0(t) and wˆ(t) under
other scenarios are provided in Appendix A.
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Figure 2.1: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2 (left)
and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles
of the IMSE when h0(t) = t/2, w(t) = log(t) and n = 500.
2.5 Application
We now apply the proposed method to model mortality and hospitalization outcomes
for patients on HD. Baseline covariates are collected from 1999 HD patients from January
1, 2007 to December 31, 2007. Survival time, the number of hospital admissions and total
length of stay of these patients during the period of January 1, 2008 and December 31,
2009 are collected. 1078 (53.93%) patients are male. 984 (49.22%) patients are black,
834 (41.72%) patients are white, the rest are from other races.
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Table 2.6: Summary statistics of covariates
(Min, Max) Mean (Std)
Age (year) (1.00, 96.62) 62.39 (14.84)
BMI (kg/m2) (13.75, 49.51) 27.65 (6.46)
Albumin (g/dL) (1.60, 4.74) 3.84 (0.37)
IDWG (%) (0.41, 7.99) 3.48 (1.05)
PreSBP (mmHg) (81.88, 219.29) 149.38 (18.86)
eKt/V (0.68, 3.77) 1.46 (0.26)
NLR (0.51, 31.18) 3.70 (2.32)
Vintage (year) (0.08, 7.90) 2.56 (1.92)
In previous studies, albumin and systolic blood pressure prior to dialysis (PreSBP)
have been found as significant risk factors for mortality [45, 25, 28]. Albumin serves
as an indication of nutrition levels. Erdem et al. observed that HD patients with high
neutrophil-to-lymphocyte ratio (NLR) levels have increased risk of short term mortality
as it has been discovered as an important marker of inflammation in ESRD patients [14].
Our preliminary data analytical results indicate that vintage, inter-dialytic weight gain
(IDWG) and eKt/V also have significant effect on mortality. Vintage is recorded as the
time in years since the patient initiated dialysis. IDWG is measured at the beginning of
dialysis and excessive IDWG is usually related to the overload of sodium and water in
the body and indicates a poor residual kidney function. eKt/V is a quantity comparing
the level of urea in the blood before and after dialysis, and serves as a measurement
of dialysis adequacy. Larger level of eKt/V implies that more waste is cleared from
the body through dialysis. Each time-varying covariates is summarized by its mean in
baseline period for each patient. In addition, I will include gender, race and BMI as
potential risk factors. The summary statistics for these covariates are listed in Table 2.6.
In modeling the hospitalization, the number of hospital admissions is usually the
primary outcome which will be studied in Section 2.5.1 using a Poisson model. We are
sometimes also interested in whether a patient has ever been hospitalized as a binary
18
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outcome. Since the probability of ever been hospitalized can be derived from the Poisson
model, I omit the details of modeling the binary outcome in this chapter. Given the
subject has been hospitalized, a further goal is to identify the risk factors that lead to
longer total length of stay which will be studied in Section 2.5.2 using a Gamma model.
For simplicity I will consider the same set of covariates for all models.
2.5.1 Joint Analysis of Mortality and Hospital Admission
359 (17.96%) patients died during the follow-up period. The number of hospital
admissions in the data ranges from 0 to 37 with mean 2.53. We consider the following
joint model:
hi(t|νi) = h0(t) exp{β1 ∗ Agei + β2 ∗ Albumini + β3 ∗ PreSBPi + β4 ∗NLRi
+ β5 ∗BMIi + β6 ∗Malei + β7 ∗ IDWGi + β8 ∗ eKt/Vi
+ β9 ∗ V intagei + β10 ∗RaceWhitei + β11 ∗RaceBlacki + νi},
g(E(Yi|Ti, νi)) = w(Ti) + α1 ∗ Agei + α2 ∗ Albumini + α3 ∗ PreSBPi + α4 ∗NLRi
+ α5 ∗BMIi + α6 ∗Malei + α7 ∗ IDWGi + α8 ∗ eKt/Vi
+ α9 ∗ V intagei + α10 ∗RaceWhitei + α11 ∗RaceBlacki + ηνi,
(2.5)
where Yi represents the number of hospital admissions of patient i and is assumed to
follow a Poisson distribution, and νi
iid∼ N(0, σ2). We use log link g(.) = log(.).
As in the previous section I set the interior knots for baseline hazard and offset
function equally spaced within the time period. The number of interior knots ranges
from 2 to 4. Among all the combinations, the AIC selects 2 knots for the baseline hazard
and 2 knots for the offset function.
I summarize the estimation results in Table 2.7. All covariates except BMI have sig-
19
Joint Modeling of Mortality and Hospitalization with Cross-Sectional Data Chapter 2
0.0 0.5 1.0 1.5 2.0
0
1
2
3
4
t (year)
h 0
(t)
Estimate
95% Confidence Interval
0.0 0.5 1.0 1.5 2.0
−
4
−
2
0
2
4
6
t (year)
w
(t)
Estimate
95% Confidence Interval
Log function
Figure 2.2: The estimated baseline function h0(t) and offset function w(t) for the joint
model of mortality and number of hospitalization.
nificant effect on the expected number of hospital admissions, while age, albumin, NLR,
eKt/V and vintage have significant effect on the hazard function. Overall age, NLR and
vintage are positively associated with both survival hazard and the number of hospi-
tal admissions, while albumin and eKt/V are negatively associated with the outcomes.
Furthermore, pre-dialysis SBP and IDWG are positively associated with the number of
hospital admissions, and female patients tend to have more hospital admissions. The
directions of associations are as expected.
The latent random variable is significant (σˆ2 = 0.6008, p = 0.0057), which supports
the model with random effect. Furthermore ηˆ is significantly larger than 0 (p < 0.0001).
It implies that the survival time and the number of hospital admissions are positive
correlated. The estimated baseline function h0(t) and offset function w(t) are shown
in Figure 3.2. While our model allows for inhomogeneous Poison model, the logarithm
function is close to the estimated offset function and well within the 95% confidence
20
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Table 2.7: Analysis of ESRD data
Covariates Estimate SE p-value
Mortality Age 0.0355 0.0048 < 0.0001
Albumin -1.2736 0.1681 < 0.0001
PreSBP -0.0004 0.0031 0.8990
NLR 0.1061 0.0217 < 0.0001
BMI -0.0198 0.0106 0.0619
Male 0.0748 0.1210 0.5365
IDWG 0.0684 0.0625 0.2737
eKt/V -0.5936 0.2474 0.0165
Vintage 0.1244 0.0307 < 0.0001
Race(White) 0.1341 0.2151 0.5329
Race(Black) -0.2446 0.2184 0.2629
Hospitalization Age 0.0089 0.0022 < 0.0001
Albumin -0.8126 0.0856 < 0.0001
PreSBP 0.0072 0.0015 < 0.0001
NLR 0.0776 0.0129 < 0.0001
BMI -0.0026 0.0049 0.5974
Male -0.1612 0.0600 0.0073
IDWG 0.1018 0.0307 0.0009
eKt/V -0.2360 0.1170 0.0437
Vintage 0.0386 0.0157 0.0140
Race(White) 0.2634 0.1094 0.0162
Race(Black) 0.3130 0.1069 0.0035
σ2 0.6008 0.2172 0.0057
η 1.2225 0.2039 < 0.0001
intervals, suggesting that it is reasonable to model the offset function by the logarithm
function in this case.
2.5.2 Joint Analysis of Mortality and Total Length of Stay
To further investigate the features of patients with hospitalizations, another interest-
ing application is to model mortality and total length of hospital stay. We will focus on
the patients who had non-zero length of stays (1396 patients). The total length of stay
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ranges from 1 to 368 with mean 26.13. We consider the following joint model:
hi(t|νi) = h0(t) exp{β1 ∗ Agei + β2 ∗ Albumini + β3 ∗ PreSBPi + β4 ∗NLRi
+ β5 ∗BMIi + β6 ∗Malei + β7 ∗ IDWGi + β8 ∗ eKt/Vi
+ β9 ∗ V intagei + β10 ∗RaceWhitei + β11 ∗RaceBlacki + νi},
g(E(Yi|Ti, νi)) = w(Ti) + α1 ∗ Agei + α2 ∗ Albumini + α3 ∗ PreSBPi + α4 ∗NLRi
+ α5 ∗BMIi + α6 ∗Malei + α7 ∗ IDWGi + α8 ∗ eKt/Vi
+ α9 ∗ V intagei + α10 ∗RaceWhitei + α11 ∗RaceBlacki + ηνi,
(2.6)
where Yi represents the total length of stay of patient i and is assumed to follow a Gamma
distribution, and νi
iid∼ N(0, σ2). We use natural log link function g(.) = log(.).
Similar process for knots selection applies, which results in 2 knots for the baseline
hazard and 2 knots for the offset function. The estimation results are summarized in Table
2.8. All covariates except BMI and vintage have significant effect on the expectation of
total length of stay, while age, albumin, NLR and vintage have significant effect on
the hazard function. We note that the results of this subsection are consistent with
those in the previous subsection. The latent random variable is borderline significant
(σˆ2 = 0.2108, p = 0.0542). The estimated baseline function h0(t) and offset function
w(t) are shown in Figure 2.3.
2.6 Discussion
In this chapter, we propose a semi-parametric joint model for survival time and hos-
pitalization. In particular, we consider the number of hospital admissions and total
length of stay as hospitalization outcomes. A shared random effect is introduced to
accommodate heterogeneity among subjects. The baseline hazard and offset functions
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Table 2.8: Analysis of ESRD data
Covariates Estimate SE p-value
Mortality Age 0.0302 0.0053 < 0.0001
Albumin -1.0237 0.1730 < 0.0001
PreSBP -0.0040 0.0035 0.2472
NLR 0.0751 0.0228 0.0010
BMI -0.0204 0.0118 0.0843
Male 0.0830 0.1340 0.5359
IDWG 0.0939 0.0704 0.1826
eKt/V -0.4920 0.0704 0.0812
Vintage 0.0944 0.0332 0.0045
Race(White) -0.0361 0.2303 0.8754
Race(Black) -0.3373 0.2335 0.1489
Length of Stay Age 0.0070 0.0022 0.0017
Albumin -0.5335 0.0870 < 0.0001
PreSBP 0.0047 0.0016 0.0036
NLR 0.0484 0.0137 0.0004
BMI -0.0045 0.0051 0.3788
Male -0.1269 0.0626 0.0430
IDWG 0.0740 0.0319 0.0205
eKt/V -0.2495 0.1234 0.0433
Vintage 0.0275 0.0165 0.0955
Race(White) 0.1338 0.1123 0.2336
Race(Black) 0.2933 0.1110 0.0084
σ2 0.2108 0.1094 0.0542
η 1.8883 0.5550 0.0007
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Figure 2.3: The estimated baseline function h0(t) and offset function w(t) for the joint
model of mortality and total length of stay.
are modeled non-parametrically through B-spline or monotone B-spline bases in order to
gain flexibility. With fixed number of knots, the techniques to numerically obtain max-
imum likelihood estimation are presented. We have also discussed the AIC method for
selecting the number of knots. Standard large sample properties of maximum likelihood
estimation apply when knots are fixed. Simulation results indicate that the proposed
estimation method performs well.
Throughout this chapter, we assume Normal distribution for the random effect. Our
method can be easily generalized to other parametric distributions for the random effect.
We have analyzed the different aspects of the hospitalization separately. One future
research is to build a joint model for survival time, hospital admission and length of stay.
Zero-inflated Poisson model can also be incorporated to account for the fact that a large
number of zeros. It is worth noting here that even though we focus on the joint modeling
of survival time and hospitalization in this research, the model and estimation method we
24
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proposed is in fact general in theory. It can accommodate the joint modeling of survival
time and any outcome which can be reasonably assumes to follow a distribution from
Exponential family.
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Chapter 3
Joint Modeling of Hospitalization
and Readmission
3.1 Introduction and Related Work
Hospitalization and readmission are increasing focuses for medical researchers and
policy makers. Readmission refers to a patient being admitted to a hospital within a
certain time period from an initial admission. Medicare uses 30 days as the time period.
If a hospital has a high proportion of patients readmitted within a short time frame, it
may be an indication of inadequate quality of care in the hospital or a lack of appropriate
coordination of postdischarge care.
Hospital admissions and readmissions are expensive. A variety of intervention pro-
grams have been implemented to reduce hospital readmission rates. Hansen et al. pro-
vided an excellent systematic review of 43 reports and articles of such intervention pro-
grams published between January 1975 and January 2011 [23].
Objective methods are required to evaluate the effectiveness of intervention programs.
Traditional evaluation methods focus on the readmission after one initial hospitalization
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during a specified observational period. Logistic regression or Cox proportional haz-
ard models are commonly used to model the rate and time of readmission [54, 24, 53].
However, one patient may experience multiple initial hospitalizations and/or multiple
readmissions. Focusing only on one initial occurrence of hospitalization and/or one read-
mission does not take full advantage of whole data.
Considering all hospitalizations during the period brings two challenges: 1) outcomes
are correlated among the same subject; and 2) number of readmissions is naturally
bounded by the number of total hospitalizations. A joint modeling approach is needed
to consider these two outcomes simultaneously.
This research is motivated by the need of evaluation of an intervention program im-
plemented by Fresenius Medical Care for ESRD patients who are on hemodialysis (HD).
The intervention program is a combination of targeted interventions. This program in-
volves a post-hospital care management system, including pre- and post-hospital checking
lists, regular follow-up on patients’ post-hospital needs and adherence to the discharge
instructions, and a centralized approach for transfer of patient among providers. It is of
interest to evaluate the program performance in reducing number of hospitalizations and
readmissions.
The aim of this research is to develop a joint modeling approach for the analysis
of hospitalization and readmission. The rest of this chapter is organized as following:
Section 3.2 introduces the statistical model for the joint analysis. Section 3.3 discusses
the estimation procedure using SAS Proc NLMIXED and the selection of number of
knots. Systematic simulation results are demonstrated in Section 3.4. The proposed joint
modeling framework is applied to evaluate the performance of the intervention program
from Fresenius Medical Care in reducing number of hospitalizations and readmissions.
The results are presented in Section 3.5. Finally this chapter ends with a conclusion in
Section 3.6.
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3.2 Model Formulation
For each patient, we observe numbers of hospital admissions and readmissions as two
outcomes. Let Yij, Zij and Xij be the number of hospitalizations, the number of hospital
readmissions and a vector of covariates for patient i at time period j, i = 1, · · · , n,
j = 1, · · · , ni.
We begin by modeling the number of hospitalizations with log linear model with
random intercept. We assume that given covariates XYij , Yij follows Poisson distribution
with mean λij and
Yij|bi ∼ Poisson(λij),
log(λij) = log(Tij) + α0 +αX
Y
ij + bi,
(3.1)
where Tij is the exposure time for patient i in period j and bi is the random intercept.
We assume that bi
iid∼ N(0, σ2).
We then treat number of hospital readmission Zij as a Binomial random variable
with total number of trials Yij and probability pij, and model pij with a semi-parametric
logistic regression model with random intercept. Specifically, we assume that
Zij|Yij,XZij ∼ Binom(Yij, pij),
logit(pij) = f(Yij) + γX
Z
ij + ηbi.
(3.2)
The random effect bi is shared by (3.1) and (3.2) to accommodate the correlation between
the observations from the same subjuect i. η is a scale parameter, which allows the
random effect bi to have different impact on each of the two responses. X
Y
ij and X
Z
ij are
part of the vector X ij and they do not need to be the same.
The probability pij may depend on Yij. We introduce function f(Yij) into the model
to account for the potential association. The form of f(Yij) is often unknown in practice
and we will model it non-parametrically.
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We assume that f(x) is a smooth function and propose to use a natural cubic spline
to model it. Natural cubic spline is piecewise cubic polynomials joined at pre-determined
knots where first-order and second-order derivatives of the function are constrained to be
continuous. In addition it requires the evaluations of second order derivative at boundary
points to equal 0. The spline function is then modeled by a linear combination of B-spline
basis functions
f(x) =
h∑
k=1
dkBk(x|τ),
where Bk(x|τ) denote the evaluation at x of the kth B-spline basis functions, generated
with internal knots τ = {t1, t2, · · · , th}. The function f(x) is decided by coefficients dk
as well as the number and locations of knots.
3.3 Estimation
For a fixed number and location of knots, the likelihood function can be obtained
by integrating out the latent random variable with respect to its density. We define
Yi = (Yi1, · · · , Yini) and Zi = (Zi1, · · · , Zini), the likelihood function for subject i is
li(Θ|Yi,Zi) =
∫
f(Yi,Zi|bi)fb(bi)dbi,
where Θ = (α0,α,γ, η, σ
2,d) is the parameter vector and fb(bi) is the density function
for the latent random variable bi.
We can further express f(Yi,Zi|bi) as the product of conditional densities:
f(Yi,Zi|bi) = fY (Yi|bi)fZ(Zi|Yi, bi)
∝
ni∏
j=1
λ
Yij
ij exp(−λij)
ni∏
j=1
p
Zij
ij (1− pij)Yij−Zij .
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We defind Y = (Y1, · · · ,Yn), Z = (Z1, · · · ,Zn), the full log likelihood is:
l(Θ|Y,Z) ∝
n∏
i=1
∫ ni∏
j=1
λ
Yij
ij exp(−λij)
ni∏
j=1
p
Zij
ij (1− pij)Yij−Zijfb(bi)dbi. (3.3)
Then it is our goal to obtain parameter estimates by maximizing the likelihood. I
adopt a similar computational approach as in Chapter 2 using SAS Proc NLMIXED
for its flexibility to provide a user-specific likelihood function with respect to random
effects. This procedure approximates the integral numerically using Gaussian quadrature
method and finds maximizers using the Newton-Raphson methods. A Newton-Raphson
ridge optimization is employed here for stable results [38]. Random effect νˆi is estimated
by the empirical Bayes estimators νˆi that maximize f(Yi,Zi|bi)fb(bi).
To select the number and location of knots, we propose a data-driven method to
strike the balance between goodness-of-fit and model complexity. Suppose we have h
knots τ1, τ2, · · · , τh, where τi is placed at the (i− 1)/(h− 1)th percentile of the observed
Yij. τ1 and τh are the minimum and maximum of Yij. We then select the optimal h by
minimizing the AIC [1]:
AIC(h) = −2 logL+ 2h.
3.4 Simulations
We set ni = 1 or 2. We randomly assigned subjects such that they are observed
only in 1 period with probability 0.4 and in 2 periods with probability 0.6. Subjects are
randomly assigned to two treatment groups with same probability.
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We generate the simulation sample from the following model:
Yij|bi ∼ Poisson(λij),
log(λij) = α0 + α1 ∗ groupi + α2 ∗ periodij + bi,
Zij|Yij, bi ∼ Binom(Yij, pij),
logit(pij) = f(Yij) + γ1 ∗ groupi + γ2 ∗ periodij + ηbi,
bi
i.i.d.∼ N(0, σ2).
(3.4)
We consider two situations for the function f(x): linear and quadratic. Knots are
placed at percentiles of the values of Yij’s in the sample. The number of interior knots
are selected as the minimizer of AIC among three values: 3, 4 and 5. Simulation results
are based on 500 replicates in each scenario.
As a comparison, we have also conducted the simulation by separate modeling (SM)
where there is no shared random variable bi, and Yij and Zij are modeled marginally
with a log-linear model and a logistic regression respectively. The estimation results for
parameters are listed in Tables 3.1 and 3.2. Our joint model (JM) has small bias and
MSE, and the coverage probability is closed to nominal value. Moreover, the performance
of estimation improves when we increase sample size. The estimates from SM for some
parameters are severely biased, especially α0, γ1, γ2. The coverage probabilities generally
are poor for SM and increasing sample size does not improve the performance. The
simulation results verifies the necessity of modeling two responses jointly when they are
correlated.
We investigate the performance of curve fitting by their sum weighted mean square
error (SWMSE) defined as
SWMSE(fˆ) =
N∑
i=1
wi(fˆ(xi)− f(xi))2, (3.5)
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Table 3.1: Mean squared error (MSE), bias and coverage of 95% confidence intervals
(CP) based on the joint model (JM) and the separate model (SM).
JM SM
f(x) = 0.5 + 0.1x Parameter True Bias MSE CP Bias MSE CP
n = 400 α0 0.5 .000 .004 .952 .123 .019 .338
α1 -0.2 -.004 .006 .966 -.004 .006 .896
α2 -0.2 -.002 .004 .964 -.002 .005 .952
γ1 -0.2 .000 .026 .942 .064 .027 .906
γ2 -0.2 -.005 .023 .954 .058 .025 .942
η 1 -.012 .130 .966 - - -
σ2 0.25 -.004 .003 .934 - - -
n = 600 α0 0.5 .000 .003 .938 .124 .018 .174
α1 -0.2 -.003 .004 .960 -.003 .004 .890
α2 -0.2 -.002 .003 .950 -.002 .003 .940
γ1 -0.2 -.002 .017 .946 .064 .019 .910
γ2 -0.2 -.003 .018 .930 .062 .021 .896
η 1 .005 .095 .960 - - -
σ2 0.25 -.001 .002 .946 - - -
n = 800 α0 0.5 .000 .002 .948 .126 .018 .086
α1 -0.2 -.003 .003 .952 -.003 .003 .864
α2 -0.2 -.001 .003 .942 -.001 .003 .928
γ1 -0.2 -.003 .013 .948 .063 .015 .900
γ2 -0.2 -.004 .012 .952 .059 .014 .928
η 1 -.007 .073 .948 - - -
σ2 0.25 .001 .001 .938 - - -
where x1, . . . , xN are integers from 0 to the maximum value of Yij in the sample.
Here we use weight wi in Equation (3.5) proportional to the observed frequency of xi
in the data. Figure 3.4 provides the 5th, 25th, 50th, 75th and 95th best estimates of fˆ(x)
ordered by SWMSE when the true function is linear and quadratic respectively. Overall,
the estimates are close to the true functions when sample size is median or large.
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Table 3.2: Mean squared error (MSE), bias and coverage of 95% confidence intervals
(CP) based on the joint model.
JM SM
f(x) = 0.02(x− 5)2 Parameter True Bias MSE CP Bias MSE CP
n = 400 α0 0.5 .002 .004 .942 .126 .020 .290
α1 -0.2 -.004 .007 .954 -.004 .007 .854
α2 -0.2 -.001 .071 .944 -.002 .005 .934
γ1 -0.2 .002 .023 .936 .068 .025 .884
γ2 -0.2 .001 .021 .954 .065 .023 .934
η 1 -.040 .134 .964 - - -
σ2 0.25 -.004 .002 .936 - - -
n = 600 α0 0.50 .001 .003 .938 .124 .018 .174
α1 -0.20 -.001 .005 .936 -.001 .005 .840
α2 -0.20 .001 .003 .964 .001 .003 .952
γ1 -0.20 .000 .016 .934 .067 .019 .866
γ2 -0.20 -.003 .014 .952 .062 .017 .920
η 1 -.025 .082 .950 - - -
σ2 0.25 -.004 .001 .946 - - -
n = 800 α0 0.50 .000 .002 .940 .124 .017 .104
α1 -0.20 .002 .003 .964 .001 .004 .868
α2 -0.20 .000 .002 .972 .000 .002 .954
γ1 -0.20 .007 .012 .934 .074 .015 .848
γ2 -0.20 -.003 .010 .950 .063 .013 .884
η 1 -.017 .058 .966 - - -
σ2 0.25 -.002 .001 .962 - - -
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Figure 3.1: True function (solid lines) and estimates (dashed lines) of f(Y ) (left)
correspond to the 5th, 25th, 50th, 75th and 95th percentiles of the SWMSE when
f(Y ) is linear (top) or quadratic (bottom).
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3.5 Application
We apply our method to an observational study of ESRD patients. The data come
from Fresenius Medical Care. There are two treatment groups: intervention group and
control group. The intervention group includes 26 clinics in West Virginia, and the
control group includes 18 clinics from other places. Clinics in the control group were
matched to those in the intervention group based on Urban vs. rural, clinic size, hospital
admission rate and percent of readmissions within 30 days. We have 1730 and 1400 pa-
tients in each group respectively. The intervention was applied to patients in 2013. Each
patient is expected to be observed in two periods: 1) Before treatment: 12 months end-
ing 12/31/2012 and 2) After treatment: 12 months ending 12/31/2014. However some
patients died or lost-to-follow in the After period. In the intervention group, there are
889 patients who have both observations and 841 patients who only have the observation
in Before period. In the control group, there are 749 patients who have both observa-
tions and 651 patients who only have the observation in Before period. The number
of hospitalization admissions and readmissions are recorded. Summaries are provided
in Table 3.3. Other covariates include age, vintage, gender, and comorbidities diabetes,
congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD). Ages
of the patients in our data range from 2.4 to 98.8 years with mean 61.4. Vintage is the
number of years since the patient started dialysis, it ranges from 0.002 to 28.613 years
with mean 2.497. 56.26% of patients are male. The proportions of diabetes, CHF and
COPD patients in our data are 68.56%, 18.18% and 9.11% respectively.
The motivation of this analysis is to investigate the effect of intervention program on
both the hospitalization and readmission rate. Since hospitalization will naturally change
over time with patients’ disease progression, as illustrated in Table 3.3, our main goal
is to test whether intervention changes the difference between the outcomes in Before
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Table 3.3: Mean (SE) of the number of hospitalizations and readmissions.
Before After
Hospitalization Intervention 1.82 (2.23) 1.50 (2.12)
Control 1.57 (2.20) 1.46 (1.98)
Readmission Intervention 0.65 (1.41) 0.49 (1.32)
Control 0.55 (1.45) 0.45 (1.20)
period and After period. The model is fitted as
Yij|Xij ∼ Poisson(λij),
log(λij) = log(Expij) + α0 + α1Trti + α2Prdij + α3(Trti × Prdij) + α4Ageij
+ α5V intageij + α6Malei + α7Diabetici + α8CHFi + α9COPDi + bi,
Zij|Yij,Xij ∼ Binom(Yij, pij),
logit(pij) = f(Yij) + γ1Trti + γ2Prdij + γ3(Trti × Prdij) + γ4Ageij
+ γ5V intageij + γ6Malei + γ7Diabetici + γ8CHFi + γ9COPDi + ηbi,
bi
i.i.d.∼ N(0, σ2),
where we define Trti = 1 if patient i is assigned to treatment group and 0 otherwise.
Prdij = 0 if patient i is observed in Before period, and Prdij = 1 if in After period, j = 1
or 2 respectively. Expij is the exposure time of patient i in period j. To test the impact
of intervention on hospitalization and readmission, it is equivalent to test H0 : α3 = 0
and H0 : γ3 = 0 respectively. Parameter estimates are listed in Table 2.7. We select the
number of knots as the minimizer of AIC among three values, 2, 3 and 4.
From Table 3.4, we can conclude that intervention has significantly reduced the num-
ber of hospitalizations (αˆ3 = −0.218, p-value = 0.016), while its impact on readmission
rate is not significant. Age, diabetes, COPD are positively associated with number of
hospitalizations. Vintage, male are negatively associated with the number of hospital-
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Table 3.4: Parameter estimation for the ESRD data.
Hospitalization Readmission
Estimation Error p-value Estimation Error p-value
Intercept -0.053 0.115 0.647
Treatment 0.177 0.053 0.001 0.058 0.078 0.458
Period -0.216 0.068 0.002 -0.136 0.107 0.205
Trt*Prd -0.218 0.090 0.016 -0.010 0.140 0.942
Age 0.004 0.002 0.003 0.006 0.002 0.012
Vintage -0.020 0.007 0.007 -0.015 0.011 0.188
Male -0.094 0.042 0.027 0.028 0.064 0.698
Diabetic 0.283 0.048 < 0.001 0.058 0.076 0.443
CHF 0.004 0.053 0.937 -0.126 0.082 0.125
COPD 0.192 0.068 0.005 0.081 0.101 0.425
σ2 1.128 0.047 < 0.001
η 0.812 0.063 < 0.001
izations. Only age is positively associated with readmission rate.
The estimates of both σˆ2 and ηˆ are significantly different from 0 at significance level
0.05, which suggests that the correlation among outcomes from the same patient is non-
ignorable. Figure 3.2 shows the fitted curve fˆ(x) and its 95% pointwise confidence
interval. We can observe that it is an increasing linear function.
3.6 Conclusion
The methods proposed in this chapter fill the gap of statistical methodologies on eval-
uating intervention effect on both hospitalization and readmission rate. A joint modeling
approach is proposed treating the number of hospitalizations as observations from Pois-
son distribution and number of readmissions as observations from Binomial distribution
with the total number of trials being the number of hospitalizations. The means of the
Poisson distribution and Binomial distribution are linked by shared random effects.
The estimation procedure can be conveniently carried out by SAS Proc NLMIXED.
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Figure 3.2: Fitted fˆ(x) in ESRD data and its 95% pointwise confidence interval.
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The simulation demonstrates good estimation properties. Furthermore, by comparison
of the estimation between joint analysis and separate modeling, we found that separate
modeling neglecting the possible correlation introduces biases on the treatment effects.
The proposed joint modeling framework is applied to a real world example to examine
the effect of an intervention program on reducing number of hospitalizations and admis-
sions. Data analytical results show that this program effectively reduces the number
of hospitalizations, however its effect on reducing rate of readmission is not significant
comparing with the control group.
It may be noticed that in the application, only a subset of patients are observed in both
before intervention and after intervention period. This is caused by the death or censoring
of patients during the time period in-between. As mortality is another important measure
of treatment effect and is underlying associated with patients’ health condition, it is
desirable to include it as one of the outcomes and model it with hospitalization and
readmission jointly. This is one potential direction of our future research.
We considered all-cause readmission. Planned and unplanned readmissions are mixedly
observed and unbraiding the two provides different interpretation of statistical analysis.
However it is beyond the scope of this research. See Kossovsky et al. about distinctions
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between planned and unplanned readmissions [36].
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Chapter 4
Variable Selection in Joint Modeling
of Multivariate Longitudinal and
Survival Data
4.1 Introduction and Literature Review
Joint modeling of longitudinal measurements and survival data has attracted a great
deal of attention. Both longitudinal measurements and survival time may be driven by
an underlying biological process which governs the health condition of patients. The
complicated features in the data structure brings challenges in statistical modeling. Pre-
vious studies have shown that a naive combination of longitudinal and survival time
data analyses neglecting the dependence structure will lead to bias [40, 62]. Model-
ing the longitudinal measurements and survival time jointly reduces biases and provides
improvements of efficiency in the estimates [32].
The joint modeling framework links a submodel for longitudinal processes and a
submodel for survival time. Cox proportional hazard model for the survival time has
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been widely adopted in literature. Standard approaches for the longitudinal process are
mixed effect models [62, 9, 17, 56, 31]. These models assume that true longitudinal process
(without measurement error) changes smoothly, possibly depending on time-independent
covariates and subject-specific random effects. Excellent reviews were given by Tsiatis
and Davidian [58] and Rizopoulos [48]. Some other authors introduced a stochastic
process as time varying frailty which can be regarded as biological fluctuations in the
process as disease progresses (eg, Wang and Taylor discussed integrated OU process [61],
Henderson et al. suggested stationary Gaussian process [27]). To allow for more flexibility
in modeling of longitudinal measurements, Tsiatis and Davidian specified nonparametric
distributions for the random effects [57] while Brown, Ibrahim and DeGruttola proposed
a multivariate B-Spline model for the longitudinal biomarkers [4].
Variable selection is an essential topic in statistical modeling, for improved inference
and interpretation. Many classical methods such as Akaike information criterion (AIC)
[1], Bayesian information criterion (BIC) [51], Mallow’s Cp [41] and risk inflation crite-
rion (RIC) [19] have been developed to compare different models. These methods are
computationally intensive when the number of models is large. Regularization methods
are widely used for variable selection for high dimensional data [5]. Tibshirani proposed
the famous LASSO method for fixed-effect selection in linear models [55]. Other types
of penalties, including SCAD [16], elastic-net [65] and adaptive LASSO [64], are well
studied. Bondell et al. [2] and Ibrahim et al. [33] studied the selection of fixed and
random effects in mixed effect models. Fan et al. provided a systematic review on the
variable selection methods for survival analysis and proposed a unified nonconcave penal-
ized likelihood approach [15]. However research of variable selection in the joint modeling
framework is still limited.
Recently He et al. [26] proposed a variable selection method for the fixed effects and
random effects in the joint modeling of one longitudinal biomarker and the survival time
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. In many situations there does not exist a single biomarker and multiple variables are
observed longitudinally. For example, ESRD patients suffer from many comorbidities.
The reduced kidney function is accompanied by numerous metabolic changes which affect
almost all organ systems of the human boby. Therefore multiple biological changes of
the patients need to be monitored.
The goal of this research is to develop a joint modeling framework linking multivariate
longitudinal processes and survival time. A penalized likelihood approach is proposed
to perform variable selection and estimation simultaneously. The rest of this chapter is
organized as follows. Section 4.2 introduces the joint model. Section 4.3 proposes the pe-
nalized likelihood estimation method. Section 4.4 discusses details about our estimation
procedure. Sections 4.5 and 4.6 present simulation results and applications to patients
on HD. The chapter ends with a discussion in Section 4.7.
4.2 Model Formulation
For each subject i, i = 1, · · · , n, we observe J longitudinal outcomes yij, j = 1, · · · , J ,
at time points tijk, k = 1, · · · , Kij. The observation time points may be different for each
longitudinal outcome and for each subject. Denote Di as the death time of subject i
which is subject to right censoring at censoring time Ci. We denote Ti = min{Ci, Di} as
the observed time, and ∆i = I(Di < Ci) as the death event indicator.
For longitudinal outcomes, consider the following multivariate linear mixed effect
model:
yij(tijk) = X
′
iαj + βj1 + bij1 + (βj2 + bij2)tijk + ijk, (4.1)
where X ′i is the vector of fixed covariates for the longitudinal outcomes of subject i,
βj1 and βj2 are population mean intercept and slope for the jth longitudinal outcome
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respectively, bij1 and bij2 are the subject-specific random intercept and slope for subject i
respectively and ijk are random errors. We denote bi = (bi11, bi12, bi21, bi22, · · · , biJ1, biJ2)′
as the vector of random effects of subject i and assume bi follows a 2J-dimension multi-
variate Normal distribution, bi
iid∼ N(0,Σ). We assume that ijk iid∼ N(0, σ2) and further-
more they are independent of subject-specific random effects bi for all i, j, k.
For the survival outcome, we consider the Cox proportional hazard model:
hi(t) = h0(t) exp{X ′iγ0 + b′iγ}, (4.2)
where h0(t) is the baseline hazard function and X
′
i is the vector of fixed covariates.
Subject-specific random intercepts and slopes for longitudinal covariates bi are also in-
cluded as features of the longitudinal trajectories. Therefore bi is the key component in
our joint modeling framework since it is responsible for not only the correlation among
multiple longitudinal covariates but also the correlation between survival time and longi-
tudinal outcome. Since bi’s are the ith subject’s deviation from population mean inter-
cept and population mean slope, exp(γ) is interpreted as the hazard ratio of increasing
one unit of subject intercept or slope away from the population mean. The idea of in-
troducing random intercept and slope of longitudinal processes in the Cox model is not
new. A similar modeling technique has been considered by Liu and Huang [39] in 2009.
For simplicity of notation, we consider the situation where all J longitudinal outcomes
and the survival outcome shares the same set of fixed covariates. Our model formulation
can be easily generalized to the situation where the components of fixed covariates are
different in different sub-models.
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4.3 Variable Selection Through Penalized Likelihood
We denote yi = (y
′
i1,y
′
i2, · · · ,y′iJ)′ as the stacked longitudinal outcomes for subject
i, α = (α1, · · · ,αJ)′ and β = (β1, · · · ,βJ)′. Let θ be the collection of all unknown
parameters (α,β,γ0,γ, σ
2,Σ) in the model. The log likelihood can be written as
l(θ) =
n∑
i=1
log
∫
fy(yi|X i, bi;θ)fT (Ti,∆i|X i, bi, h0(Ti);θ)fb(bi)dbi, (4.3)
where fy(yi|X i, bi;θ) is the density function of the multivariate Normal random vari-
ables yi conditional on bi, fb(bi) is the density function of random effects bi, and
fT (Ti,∆i|X i, bi, h0(Ti);θ) is the likelihood function of survival outcome (Ti,∆i) con-
ditional on bi:
fT (Ti,∆i|X i, bi, h0(Ti);θ)
= {h0(Ti) exp(X ′iγ0 + b′iγ)}∆i exp
{
−
∫ Ti
0
h0(t) exp(X
′
iγ0 + b
′
iγ)dt
}
.
(4.4)
The likelihood function depends on h0(Ti). It can be modeled parametrically (e.g.
using an Exponential or Weibull distribution) or non-parametrically using a piece-wise
constant function or B-spline bases. Throughout this chapter, I present an Exponential
baseline, that is h0(Ti) equals a constant h0. Our methods can be easily adapted to other
models for the baseline function.
The aim of our research is to perform variable selection of the features of longitudinal
outcomes in the survival sub-model. In order to select the random effects bi, we consider
the following negative penalized likelihood
pl(θ) = −l(θ) + p1(γ) + p2(Σ), (4.5)
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where p1(γ) controls the sparsity of the coefficients of random intercepts and slopes in
the survival sub-model γ, and p2(Σ) controls the sparsity of the covariance matrix of bi.
For p1(γ), we consider LASSO penalty, defined as p1(γ) = nλ1||γ||1 = nλ1
∑2J
i=1 |γi|.
The LASSO penalty was first introduced by Tibshirani [55] in 1996 for fixed-effect selec-
tion in linear models. Since L1 penalty shrinks small estimates all the way towards zero,
it is a useful tool for simultaneous variable selection and parameter estimation. Therefore
the random intercepts and slopes of longitudinal covariates are selected in the survival
sub-model. As the dimension of longitudinal outcomes may be high, it is reasonable to
assume that the covariance matrix of random effects bi is sparse. Therefore, we also
consider L1 penalty for p2(Σ). We define p2(Σ) = (nλ2/2)
∑
i 6=j |σij|, where σij is the
element in Σ at ith row and jth column. Penalties are only imposed on off-diagonal
elements to avoid the non-identifiability problem in our joint model. This off-diagonal
penalty was considered on the precision matrix in graphical lasso problems by Zhang
and Zou [63]. λ1 and λ2 are tuning parameters which control the sparsity of coefficients
vector and covariance matrix respectively. It is worth mentioning that we do not penalize
the variances of random intercepts and slopes in the longitudinal sub-models as they are
essential features of trajectories, this is different than the penalty proposed by He et al.
[26]. Their research aims at the selection of random covariates and therefore imposes
penalties on the diagonal elements of covariances matrix as well.
We note that in this work we do not impose penalties on other coefficients since our
main interest is to select important longitudinal covariates in the survival sub-model.
However, our procedure can been easily generalized to penalize other coefficients, for
example, α or γ0, in order to perform variable selection of fixed covariates in longitudinal
or survival sub-models respectively.
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4.4 Computational Method
The negative penalized likelihood involves a complicated integral which does not have
a closed form, therefore solving the whole solution path is difficult. In this section, I will
propose a numeric estimation method based on coordinate descent algorithm.
4.4.1 Laplace Approximation
First, the integral in the negative penalized likelihood function is approximated by
a Laplace approximation. We start by writing the non-penalized log likelihood function
for subject i as:
l0i(θ)
= log
∫
exp{log fy(yi|X i, bi;θ) + log fT (Ti,∆i|X i, bi, h0(Ti);θ) + log fb(bi;θ)}dbi
= log
∫
exp{κ(bi)}dbi.
(4.6)
By second order Taylor expansion of κ(bi), we get the following approximation:
κ(bi) ≈ κ(b˜i) + 1
2
(bi − b˜i)′H˜bi(bi − b˜i),
where b˜i = argmax biκ(bi) and H˜bi
is the Hessian evaluated at b˜i.
Substituting the above approximation in (4.6) yields approximate log likelihood func-
tion for subject i:
l0i(θ) ≈ κ(b˜i) + log
∫
exp
{
1
2
(bi − b˜i)′H˜bi(bi − b˜i)
}
dbi.
We note that the latter term is a multivariate Gaussian integral up to a constant and
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therefore
l0i(θ) ≈ κ(b˜i)− 1
2
log | −H˜bi |+ J log(2pi). (4.7)
4.4.2 Coordinate Descent Algorithm
Coordinate descent is an algorithm designed to optimize a multivariate objective
function. The idea is that the multivariate objective function can be optimized by opti-
mizing over each direction in a loop. In each step, one focuses on one parameter alone
while holding other parameters fixed, therefore the task of this algorithm becomes the
optimization of a sequence of univariate objective functions. This algorithm is easy to
implement since optimization of univariate objective functions are generally much easier
than that of multivariate objective functions.
Coordinate descent and its extensions has been proposed for optimizing objective
functions with L1 regularization a number of times, for example in linear regression
models [22, 20] or generalized linear models [52, 21]. In this section, we describe a
coordinate descent algorithm to optimize our negative penalized likelihood.
With the Laplace approximation in (4.7), the approximate penalized log-likelihood
can be written as
pl(θ) =
n∑
i=1
[
−κ(b˜i)
]
+
n∑
i=1
1
2
log | −H˜bi |+ nλ1||γ||1 + (nλ2/2)
∑
j 6=k
|σjk|, (4.8)
where σjk is the element of Σ at jth row and kth column, n is the number of subjects,
and
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−κ(b˜i) =− log fy(yi|bi)− log fT (Ti,∆i|bi)− log fb(bi)
=
ni
2
log σ2 +
(yi − µi)′(yi − µi)
2σ2
−∆i log h0 −∆i(X ′iγ0 + γ ′b˜i)
+ h0Ti exp(X
′
iγ0 + γ
′b˜i) +
1
2
log |Σ|+ 1
2
b˜
′
iΣ
−1b˜i,
Hi , H˜bi =
∂κ(bi)
∂b′i∂bi
∣∣∣∣
bi=
˜bi
= −ZiZ
′
i
σ2
− h0Ti exp(X ′iγ0 + γ ′b˜i)γγ ′ − Σ−1,
where ni is the total number of longitudinal observations for subject i, µi is the mean
vector of yi, Zi is the design matrix for bi.
The last part in Equation (4.7) is a constant and therefore is dropped.
At the beginning of the algorithm, we initialize our parameter vector θˆ
(0)
by a naive
combination of longitudinal and survival outcomes. We fit a linear mixed effects model
first on the longitudinal outcomes only to obtain estimates αˆ(0) and βˆ
(0)
. We then treat
the estimated random effects as known covariates and fit the Cox proportional hazard
model to get estimates γˆ
(0)
0 and γˆ
(0).
Then in each iteration, we first calculate b˜i , argmax biκ(bi) with the current estimates
of parameters. We use a Newton method to solve b˜i by updating equation b˜
new
i =
b˜
old
i − κ′(boldi )Hboldi , where
κ′(bi) =
(yi − µi)′Zi
σ2
+ ∆iγ
′ − h0Ti exp(X ′iγ0 + γ ′bi)− b′iΣ−1,
Hbi = −
ZiZ
′
i
σ2
− h0Ti exp(X ′iγ0 + γ ′bi)γγ ′ − Σ−1.
In the next step, we update each parameter in θ one at a time with other parameters
fixed at the value obtained in the previous iteration. Specifically, to update parameter
θˆtj → θˆt+1j , we would compute the gradient ∂pl(· · · , θˆ(t)j−1, θj, θˆ(t)j+1, · · · )/∂θj at θj = θˆ(t)j .
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Note that the gradient only exists when θˆ
(t)
j 6= 0. We then update θˆ(t)j by
θˆ
(t+1)
j ← θˆ(t)j − s(t)j
∂pl(· · · , θˆ(t)j−1, θj, θˆ(t)j+1, · · · )
∂θj
∣∣∣∣∣
θj=θˆ
(t)
j
. (4.9)
s
(t)
j in (4.9) is the step size. We use a backtracking line search scheme to select the
appropriate s
(t)
j to insure sufficient descent of objective function in each update. A sketch
of the line search algorithm is shown in Algorithm 1.
Algorithm 1 Backtracking line search algorithm
Start at s = 1, choose α ∈ (0, 1/2), β ∈ (0, 1)
repeat s← βs
until f(x− sf ′(x)) < f(x)− αs[f ′(x)]2
Partial derivatives and Hessian matrix in the updating steps are as follows:
∂pl(θ)
∂α
= −
n∑
i=1
(yi − µi)′X i
σ2
,
∂pl(θ)
∂β
= −
n∑
i=1
(yi − µi)′Zi
σ2
,
∂pl(θ)
∂γ0
=
n∑
i=1
−∆iX ′i+h0Ti exp(X ′iγ0+γ ′b˜i)X ′i−
1
2
tr(H−1i h0Tiγγ
′ exp(X ′iγ0+γ
′b˜i)X i),
∂pl(θ)
∂h0
=
n∑
i=1
−∆i
h0
+ Ti exp(X
′
iγ0 + γ
′b˜i)− 1
2
|tr(H−1i Tiγγ ′ exp(X ′iγ0 + γ ′b˜i)),
∂pl(θ)
∂γj
∣∣∣∣
γj=γ
(t)
j
=
n∑
i=1
−∆ibij + h0Ti exp(X ′iγ0 + γ(t)
′
b˜i)bij
−
n∑
i=1
tr(H−1i h0Ti exp(X
′
iγ0 + γ
(t)′ b˜i)(γ
(t)γ(t)
′
bij + 2Ijγ
(t)′)) + sign(γj)nλ1|γ(t)j |,
where Ij is a vector of length 2J , its jth element is 1 and others are 0.
∂pl(θ)
∂σ2
=
n∑
i=1
ni
2σ2
− (yi − µi)
′(yi − µi)
2(σ2)2
+
1
2
tr
(
H−1i
ZiZ
′
i
(σ2)2
)
.
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∂pl(θ)
∂σjk
∣∣∣∣
σjk=σ
(t)
jk
=
n∑
i=1
[
1
2
tr(Σ−1Ijk)− 1
2
b˜
′
iΣ
−1IjkΣ−1b˜i +
1
2
tr(H−1i Σ
−1IjkΣ−1)
]
+ I(j=k)sign(σjk)λ2n|σjk|,
where I(j=k) is a scale indicator, it equals 1 if j = k and 0 otherwise, Ijk is a matrix
indicator of dimension 2J × 2J , the elements at its jth row, kth column and kth row,
jth column are 1 and all the other elements are 0.
The estimation procedure is summarized in Algorithm 2. The algorithm iterates until
convergence. Our convergence criteria is
|pl(θ(t+1))− pl(θ(t))|
|pl(θ(t))| < δ,
where δ is a pre-specified number. We use δ = 10−6 throughout this chapter.
Algorithm 2 Coordinate Descent Algorithm
Initialize parameter vector θ(0) by fitting marginal models
repeat
Obtain b˜i which maximize κ(bi) with current estimates θ
(t)
for (each parameter θi in θ) do
Select step size s
(t)
j ;
Update θ
(t+1)
i ← θ(t)i − s(t)j ·
(
∂pl(· · · , θˆ(t)j−1, θj, θˆ(t)j+1, · · · )/∂θj
)
;
end for
t→ t+ 1
until Converge
4.4.3 Tuning Parameters
We apply the above algorithm on a grid of values of tuning parameter λ1 and λ2. The
optimal combination of λ1 and λ2 is selected by minimizing BIC:
BICλ1,λ2 = −2l(θ) + log(N) · dfλ1,λ2 ,
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where l(θ) is the log likelihood function, N is the total sample size N =
∑n
i=1 ni + n.
dfλ1,λ2 is defined as the number of effective (non-zero) estimates in the model.
4.4.4 Two-Stage Estimation
To reduce bias introduced by penalization, we use a two-stage estimation suggested
by He et al. [26]. The first stage focuses on the variable selection procedure using
penalized likelihood function. When the non-zero effects are identified, the second stage
re-estimates the model with the non-zero variables only, using non-penalized likelihood.
Our simulation results show that this two-stage estimation method reduces the biases
successfully.
4.5 Simulations
The simulation data are generated from the following model:
yij(tijk) = Xiαj + βj1 + bij1 + (βj2 + bij2)tijk + ijk, i = 1, 2, · · · , n, j = 1, · · · , J
hi(t) = h0 exp{Xiγ0 + b′iγ},
where fixed effect Xi is a binary group indicator, Xi
i.i.d.∼ Bin(0.5), γ = (1, 0, 0, 0, 0, 0, 1)
which implies that only the random intercept of the first longitudinal outcome and the
random slope of the third longitudinal outcome are non-zero, (α1, α2, α3) = (1,−1, 1).
(β11, β12, β21, β22, β31, β32) = (1,−1, 1, 1,−1, 1), h0 = 0.2, γ0 = 1, and σ2 = 0.04. Lon-
gitudinal observations are collected every 0.2 time unit from the time 0 to the death or
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censored time Ti. The following covariance matrix is considered for bi:
Σ =

0.5 0.2 0 0 0 0
0.2 0.5 0 0 0 0
0 0 0.5 0.2 0 0
0 0 0.2 0.5 0 0
0 0 0 0 0.5 0.2
0 0 0 0 0.2 0.5

We consider the following four scenarios:
• Scenario I: Censoring rate 10%, n = 500 subjects.
• Scenario II: Censoring rate 30%, n = 500 subjects.
• Scenario III: Censoring rate 10%, n = 1000 subjects.
• Scenario IV: Censoring rate 30%, n = 1000 subjects.
On average for each longitudinal outcome of each subject, 18 observations are col-
lected in scenario I and III, and 13 observations are collected in scenario II and IV. Our
simulation under each scenario is repeated 100 times.
Tables 4.1 and 4.7 present the selection frequencies of γ and covariance matrix Σ
respectively. Throughout the simulation, we use 0.05 as the cut-off value to determine
zero effects. Our variable selection procedure demonstrates excellent selection properties.
The selection frequencies of non-zero elements in γ are 100% in all scenarios and the mis-
selection rates for zero effects are well controlled. And both true positive rates and true
negative rates in the selection of components in Σ are closed to 100%. Simulation also
shows that increasing sample size and reducing censoring rate improves both selection
performance and estimation precision.
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Table 4.1: Sel. Freq.(%) of random effects in survival submodel
γ11 γ12 γ21 γ22 γ31 γ32
True 1 0 0 0 0 1
Senario I Freq. 100 0 1 0 1 100
Senario II Freq. 100 3 2 2 13 100
Senario III Freq. 100 1 0 0 3 100
Senario IV Freq. 100 0 0 0 10 100
Table 4.2: Sel. Freq.(%) of components in covariance matrix
True Positive True Negative
Scenario I 100 99.8
Scenario II 100 99.8
Scenario III 100 100
Scenario IV 100 100
Estimation results are shown in Tables 4.3, 4.4, 4.5 and 4.6. The bias of direct
estimation of random effects ranges from 0% to 25%. After post-selection estimation,
they are reduced to 0% to 6%. The estimates of fixed effects are almost the same in
direct estimation and post-selection estimation. This is reasonable because we do not
impose penalties on these parameters, and re-estimation with selected covariates using
non-penalized likelihood will not have a large impact on them. In order to evaluate
the precision of estimation of covariance matrix Σ, I use Frobenius norm to measure the
difference matrix between Σ and Σˆ. It is defined as ||Σ−Σˆ||F = (
∑
(σij− σˆij)2)1/2. Table
4.7 compares the direct estimation and post-selection estimation in all four scenarios. It
can be observed that post-selection estimation increases the precisions of Σˆ by a large
extent.
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4.6 Application
To illustrate the model, we analyze the data from an observational study of ESRD
patients on HD. The data are provided by Fresenius Medical Care. There are 872 patients
in the study. They are enrolled in the study since they have been on HD for one year
and are then observed for 1 subsequent year. The patient cohort includes 506 (58.0%)
males. 561 (64.33%) patients have diabetes. The age of patients ranges from 21 to 99
with mean 64. Patients’ survival time is monitored. Among 872 patients, 151 (17.3%)
died within the observational time period.
We also collect patients’ monthly measurements of systolic blood pressure prior to
dialysis (PreSBP), neutrophil to lymphocyte ratio (NLR), albumin, inter-dialytic weight
gain (IDWG) and eKt/V. Since NLR is heavily skewed, we consider log(NLR) in the
modeling. PreSBP is divided by 100 to ensure that the scales of the five longitudinal
covariates are approximately the same. The distribution of these variables are presented
in Figure 4.1.
To illustrate the format of the ESRD data, we randomly select 10 patients who died
during the observational period and 10 patients who were censored. The five longitudinal
observations of them are plotted in Figure 4.2. Red lines represent patients who died
and green lines represent patients who were censored. The figure illustrates that the
longitudinal measurements are not always available in each month, and the observational
times for different measurements are not always the same in the data. It is worth-
mentioning that our model does not require any specific observational scheme and can
handle this situation well.
For the five longitudinal covariates, we consider a multivariate linear mixed effect
model. Each longitudinal process is adjusted by the fixed effects of gender, diabetic and
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Figure 4.1: The histograms of longitudinal covariates: Albumin (g/dL), PreSBP/100
(mmHg/100), log(NLR), IDWG (%) and eKt/V in the data.
age:
Albumini(ti1k) = α11IMalei + α12IDiabetici + α13Agei + β11 + β12ti1k + bi11 + bi12ti1k + i1k
PreSBPi(ti2k)/100 = α21IMalei + α22IDiabetici + α23Agei + β21 + β22ti1k + bi21 + bi22ti2k + i2k
log(NLR)i(ti3k) = α31IMalei + α32IDiabetici + α33Agei + β31 + β32ti3k + bi31 + bi32ti3k + i3k
IDWGi(ti4k) = α41IMalei + α42IDiabetici + α43Agei + β41 + β42ti4k + bi41 + bi42ti4k + i4k
eKt/Vi(ti5k) = α51IMalei + α52IDiabetici + α53Agei + β51 + β52ti1k + bi51 + bi52ti5k + i5k
For mortality, we use proportional hazard model with the fixed effects of gender,
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Figure 4.2: Longitudinal observations of albumin (g/dL), PreSBP/100 (mmHg/100),
log(NLR), IDWG (%) and eKt/V from 20 random selected patients in the data. 10
patients died during the observational time, their observations are marked red. 10
other patients were censored, their observations are marked green.
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diabetic, age, and random effects in the longitudinal sub-model:
h(ti) = h0(ti) exp{γ01IMalei + γ02IDiabetici + γ03Agei + γbi},
where bi = (bi11, bi12, · · · , bi51, bi52). We assume the survival time of ESRD patients
follows an Exponential distribution, and therefore h0(ti) is a constant h0. We make this
assumption mainly for the simplicity of illustration, however, it is not entirely unrealistic.
In fact, a constant baseline hazard is suggested in the data analytic results in Chapter 2.
We apply our selection and estimation methods and present the selection and esti-
mation results of random effects in Table 4.8. The standard errors are calculated based
on the information matrix. Our procedure selects the random intercept of Albumin, the
random slope of PreSBP/100, both the random intercept and slope of log(NLR), and
the random intercept of IDWG as non-zero effects. Specifically, a high rate of survival
hazard is associated with low level of albumin at the beginning, drop in PreSBP over
time, high level of NLR at the beginning, increase of NLR over time and a high level of
IDWG in the beginning. The estimation results of fixed effects are listed in the survival
sub-model. Age is a significant risk factor. Senior patients tend to have higher survival
hazard. Table 4.10 presents the estimation results of mean intercept, mean slope and the
fixed effects in the longitudinal sub-model.
4.7 Conclusion
In this chapter, we propose a joint modeling framework for the joint analysis of mul-
tiple longitudinal outcomes and survival time. The two types of responses are correlated
through shared random intercepts and slopes in the longitudinal sub-models. A penalized
likelihood approach is introduced to perform variable selection and parameter estimation
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simultaneously. A coordinate descent algorithm is proposed to calculate the penalized
maximized likelihood estimates. Furthermore, a post-selection approach is introduced to
reduce the estimation bias resulted from the penalization.
We demonstrate through simulation that our procedure carries excellent selection
properties for both random effects and the elements of covariance matrix. The post-
selection method effectively reduced the estimation bias. The performance of estimation
procedure is further improved if we increase the sample size or decrease the censoring
rate.
Our proposed method is applied to a study of ESRD patients as an illustration. The
procedure successfully selects the non-zero random effects in the survival sub-model.
They include the random intercept of albumin, random slope of PreSBP, random inter-
cept of log(NLR), random intercept of IDWG and random slope of eKt/V. The signs of
these estimated coefficients are as expected.
In this research, I assume the survival time is from an exponential distribution for sim-
plicity. It can be easily generalized to other parametric distributions with corresponding
forms of baseline hazard. To allow flexible forms of baseline hazard, piecewise-constant
functions and B-splines can also be accommodated when the number and location of
knots are specified. In addition, as the primary of interest of this research is the selection
of non-zero longitudinal effects on the survival outcome, we only impose penalties on the
coefficients of random trajectories of longitudinal outcome and their covariance matrix.
Penalties on other parameters, for example fixed effects, could also be considered if of
interest in future practical data analysis.
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Table 4.3: Estimation of coefficients in survival submodel in scenario I
Survival Sub-model
Random Effects Fixed Effect
γ11 γ12 γ21 γ22 γ31 γ32 γ0
True 1 0 0 0 0 1 1
Direct Bias 0.130 -0.003 0.001 -0.001 -0.008 0.205 0.102
MSE 0.024 0.000 0.000 0.000 0.000 0.005 0.023
Post-Selection Bias -0.006 0.000 0.000 0.000 0.000 0.047 0.015
MSE 0.007 0.000 0.000 0.000 0.000 0.008 0.015
Longitudinal Sub-model
Fixed Intercept and Slope
β11 β12 β21 β22 β31 β32
True 1 -1 1 1 -1 1
Direct Bias 0.002 -0.007 0.001 0.007 0.002 0.099
MSE 0.002 0.001 0.002 0.001 0.002 0.011
Post-Selection Bias 0.002 -0.007 0.001 0.007 0.002 0.099
MSE 0.002 0.001 0.002 0.001 0.002 0.010
Fixed Effect
α1 α2 α3
True 1 -1 1
Direct Bias -0.003 0.002 -0.019
MSE 0.004 0.004 0.004
Post-Selection Bias -0.002 0.002 -0.019
MSE 0.004 0.004 0.004
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Table 4.4: Estimation of coefficients in survival submodel in scenario II
Survival Sub-model
Random Effects Fixed Effect
γ11 γ12 γ21 γ22 γ31 γ32 γ0
True 1 0 0 0 0 1 1
Direct Bias 0.179 -0.007 -0.001 0.002 -0.021 0.255 0.104
MSE 0.036 0.000 0.000 0.000 0.002 0.073 0.023
Post-Selection Bias 0.010 -0.006 -0.004 0.004 -0.026 0.065 0.011
MSE 0.006 0.001 0.001 0.001 0.005 0.013 0.016
Longitudinal Sub-model
Fixed Intercept and Slope
β11 β12 β21 β22 β31 β32
True 1 -1 1 1 -1 1
Direct Bias 0.003 -0.007 0.007 -0.001 0.004 0.098
MSE 0.002 0.001 0.002 0.001 0.002 0.011
Post-Selection Bias 0.003 -0.007 0.007 -0.001 0.004 0.098
MSE 0.002 0.001 0.002 0.001 0.002 0.011
Fixed Effect
α1 α2 α3
True 1 -1 1
Direct Bias -0.004 -0.013 -0.018
MSE 0.004 0.003 0.004
Post-Selection Bias -0.002 -0.013 -0.017
MSE 0.004 0.003 0.004
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Table 4.5: Estimation of coefficients in survival submodel in scenario III
Survival Sub-model
Random Effects Fixed Effect
γ11 γ12 γ21 γ22 γ31 γ32 γ0
True 1 0 0 0 0 1 1
Direct Bias 0.122 0.000 0.000 0.000 -0.007 0.198 0.025
MSE 0.018 0.000 0.000 0.000 0.000 0.042 0.011
Post-Selection Bias -0.002 -0.001 0.000 0.000 -0.003 0.049 0.000
MSE 0.003 0.000 0.000 0.000 0.000 0.005 0.009
Longitudinal Sub-model
Fixed Intercept and Slope
β11 β12 β21 β22 β31 β32
True 1 -1 1 1 -1 1
Direct Bias 0.007 -0.007 -0.000 0.006 -0.002 0.103
MSE 0.001 0.001 0.001 0.001 0.001 0.011
Post-Selection Bias 0.007 -0.007 -0.000 0.006 -0.002 0.102
MSE 0.001 0.001 0.001 0.001 0.001 0.011
Fixed Effect
α1 α2 α3
True 1 -1 1
Direct Bias -0.005 0.003 -0.016
MSE 0.002 0.002 0.002
Post-Selection Bias -0.003 0.003 -0.016
MSE 0.002 0.002 0.002
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Table 4.6: Estimation of coefficients in survival submodel in scenario IV
Survival Sub-model
Random Effects Fixed Effect
γ11 γ12 γ21 γ22 γ31 γ32 γ0
True 1 0 0 0 0 1 1
Direct Bias 0.173 -0.001 -0.000 0.000 -0.016 0.246 0.089
MSE 0.032 0.000 0.000 0.000 0.000 0.064 0.018
Post-Selection Bias 0.014 0.000 0.000 0.000 -0.019 0.059 0.019
MSE 0.003 0.000 0.000 0.000 0.003 0.008 0.010
Longitudinal Sub-model
Fixed Intercept and Slope
β11 β12 β21 β22 β31 β32
True 1 -1 1 1 -1 1
Direct Bias -0.001 -0.007 0.005 0.001 0.003 0.098
MSE 0.001 0.001 0.001 0.001 0.001 0.010
Post-Selection Bias -0.001 -0.006 0.005 0.001 0.003 0.098
MSE 0.001 0.001 0.001 0.001 0.001 0.010
Fixed Effect
α1 α2 α3
True 1 -1 1
Direct Bias 0.001 -0.005 -0.020
MSE 0.002 0.002 0.002
Post-Selection Bias 0.002 -0.005 -0.020
MSE 0.002 0.002 0.002
Table 4.7: Frobenius norms of (Σ− Σˆ) under all scenarios
True Direct Post-selection
Scenario I 0.161 0.104
Scenario II 0.162 0.107
Scenario III 0.161 0.074
Scenario IV 0.155 0.076
62
Variable Selection in Joint Modeling Chapter 4
Table 4.8: Selection and Estimation (SE) of longitudinal covariates in survival sub-model
Albumin PreSBP/100 log(NLR) IDWG eKt/V
Intercept -2.066(0.124) - 1.034(0.151) 0.115(0.056) -
Slope - -3.353(0.105) 0.795(0.156) - -
Table 4.9: Estimate (SE) of fixed effects in survival sub-model
Male Diabetic Age
0.199(0.104) 0.170(0.096) 0.004(0.001)
Table 4.10: Estimate (SE) of fixed covariates in longitudinal sub-model
Albumin PreSBP/100 log(NLR) IDWG EKTV
Intercept 4.175(0.004) 1.658(0.004) 0.784(0.004) 4.586(0.004) 1.344(0.004)
Slope -0.079(0.006) -0.023(0.006) 0.096(0.006) -0.058(0.006) -0.039(0.006)
Male 0.063(0.005) -0.051(0.005) 0.010(0.005) -0.052(0.005) -0.090(0.005)
Diabetic -0.083(0.005) 0.064(0.004) -0.029(0.005) -0.199(0.004) 0.037(0.005)
Age -0.004(0.001) -0.003(0.001) 0.007(0.001) -0.020(0.001) 0.003(0.001)
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Estimation Performance of hˆ0(t) and
wˆ(t) Under All Scenarios
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Figure A.1: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 1000.
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Figure A.2: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 500.
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Figure A.3: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 300.
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Figure A.4: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5
(left) and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th
percentiles of the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 1000.
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Figure A.5: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5
(left) and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th
percentiles of the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 500.
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Figure A.6: True function (solid lines) and estimates (dashed lines) of h0(t) = 0.5
(left) and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th
percentiles of the IMSE when h0(t) = 1/2, w(t) = log(t) and n = 300.
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Figure A.7: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = t/2, w(t) = t/2 and n = 1000.
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Figure A.8: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = t/2, w(t) = t/2 and n = 500.
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Figure A.9: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2 (left)
and w(t) = t/2 (right) correspond to the 5th, 25th, 50th, 75th and 95th percentiles of
the IMSE when h0(t) = t/2, w(t) = t/2 and n = 300.
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Figure A.10: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2
(left) and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th
percentiles of the IMSE when h0(t) = t/2, w(t) = log(t) and n = 1000.
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Figure A.11: True function (solid lines) and estimates (dashed lines) of h0(t) = t/2
(left) and w(t) = log(t) (right) correspond to the 5th, 25th, 50th, 75th and 95th
percentiles of the IMSE when h0(t) = t/2, w(t) = log(t) and n = 300.
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Appendix B
R and SAS Codes Used in Chapter 2
Here we provide the R and SAS codes for the data analysis in Chapter 2. The following
R code is used for generating B-spline bases and integrated B-spline bases in R:
library(sas7bdat)
library(splines)
# read data of patients’ survival time
train <- read.table("dat_time.csv", sep=",", header=T,
na.strings=c("NA",""))
# function to generate B-spline bases and integrated B-spline bases
# hk is number of knots for baseline
# wk is number of knots for offset function
bspline <-
function(hk, wk, cut=730/100, n=dim(train)[1], K=1000, data=train)
{
dur <- function(i,j,knots){
integrate(function(x)
as.numeric(bs(x,knots=seq(0,cut,length=knots+2)[-c(1,knots+2)],
degree=3,intercept=T, Bound=c(-1/100,731/100))[,j]),
0, tgrid[i], rel.tol=.Machine$double.eps^0.1)$value
}
t <- bs(data$time/100,
knots=seq(0,cut,length=hk+2)[-c(1,hk+2)],intercept=T,
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Bound=c(-1/100,731/100))
tgrid <- seq(0,cut,length=K)
Tgrid <- mat.or.vec(K,hk+4)
for (i in 1:K){
for (j in 1:(hk+4)){
Tgrid[i,j] <- dur(i,j,hk)
}
}
d <- t(sapply(1:n, function(x)
Tgrid[which.min(abs(tgrid-data$time[x]/100)),]))
Wgrid <- mat.or.vec(K,wk+4)
for (i in 1:K){
for (j in 1:(wk+4)){
Wgrid[i,j] <- dur(i,j,wk)
}
}
dw <- t(sapply(1:n, function(x)
Wgrid[which.min(abs(tgrid-data$time[x]/100)),]))
data.frame(patient_id=data$patient_id,t=t,d=d,dw=dw)
}
time33 <- bspline(2,2)
write.table(time22,file="dat_time22.csv",sep=",",col.names=T,row.names=F)
The following sas code is for the joint model of survival time and number of hospi-
talization:
libname JM ’~/JM2data’;
proc import datafile = ’~/JM2data/dat_time22.csv’ dbms=csv replace
out = JM.dat_time22;
run;
data JM.dat_all22;
merge JM.dat_time22 JM.dat_all;
by patient_id;
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run;
proc nlmixed data=JM.dat_all33 maxiter=4000 TECH=NRRIDG;
bounds sigma2 c1-c6 d1-d6>0;
parms c0=-2 c1=0.3 c2=0.1 c3=0.5 c4=0.2 c5=1 c6=0.1 sigma2=0.5 eta=1
a1=0.002 a2=-0.341 a3=0.003 a4=0.031 a5=-0.004 a6=-0.105
a7=0.027 a8=-0.160 a10=0.018 a11=0.231 a12=0.444
b1=0.028 b2=-0.906 b3=-0.004 b4=0.067 b5=-0.020 b6=0.095 b7=0.086
b8=-0.387 b10=0.086 b11=0.002 b12=-0.281
d1=0.1 d2=0.1 d3=0.1 d4=0.1 d5=0.1 d6=0.1;
lin_h = v + b1*age + b2*albumin_avg + b3*pre_sbp_avg + b4*nlr_avg
+ b5*post_bmi_avg + b6*male + b7*idwg_percent_avg + b8*ektv_avg
+ b9*vintage + b10*race_white +b11*race_black;
base_haz_d = d1*t_1 + d2*t_2 + d3*t_3 + d4*t_4 + d5*t_5 + d6*t_6;
cum_base_haz_d = d1*d_1 + d2*d_2 + d3*d_3 + d4*d_4 + d5*d_5 + d6*d_6;
h = base_haz_d * exp(lin_h);
S = exp(-cum_base_haz_d * exp(lin_h));
* loglik for death;
if (event=1) then loglikD = log(h) + log(S);
if (event=0) then loglikD = log(S);
* loglik for Y;
lin_Y = a1*age + a2*albumin_avg + a3*pre_sbp_avg + a4*nlr_avg
+ a5*post_bmi_avg + a6*male + a7*idwg_percent_avg + a8*ektv_avg
+ a9*vintage +a10*race_white +a11*race_black + eta*v;
w_T = c0 + c1*dw_1 + c2*dw_2 + c3*dw_3 + c4*dw_4 + c5*dw_5 + c6*dw_6;
lambda = exp(w_T + lin_Y);
loglikY = hosp_count*log(lambda) - lambda;
loglik = loglikD + loglikY;
model time ~ general(loglik);
random v ~ normal(0,sigma2) subject=patient_id out=JM.hosp22_nu;
ods output ParameterEstimates=JM.hosp22_est FitStatistics=JM.hosp22_fit;
run;
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The following sas code is for the joint model of survival time and total length of
hospital stay:
libname JM ’~/JM2data’;
data JM.dat_days22;
merge JM.dat_time22 JM.dat_all;
by patient_id;
run;
proc nlmixed data=JM.dat_days22 maxiter=4000 TECH=NRRIDG;
bounds sigma2 c1-c6 d1-d6 nu>0;
parms c0=-2 c1=1 c2=1 c3=0.1 c4=0.3 c5=0.01 c6=0.1
sigma2=1 eta=1 nu=2
a1=0.002 a2=-0.341 a3=0.003 a4=0.031 a5=-0.004 a6=-0.105
a7=0.027 a8=-0.160 a10=0.018 a11=0.231 a12=0.444
b1=0.028 b2=-0.906 b3=-0.004 b4=0.067 b5=-0.020 b6=0.095
b7=0.086 b8=-0.387 b10=0.086 b11=0.002 b12=-0.281
d1=0.4 d2=0.8 d3=0.1 d4=0.8 d5=0.2 d6=1;
lin_h = v + b1*age + b2*albumin_avg + b3*pre_sbp_avg + b4*nlr_avg
+ b5*post_bmi_avg + b6*male + b7*idwg_percent_avg + b8*ektv_avg
+ b9*vintage + b10*race_white +b11*race_black;
*h = h0 * exp(lin_h);
*S = exp(-time*h/700);
base_haz_d = d1*t_1 + d2*t_2 + d3*t_3 + d4*t_4 + d5*t_5 + d6*t_6;
cum_base_haz_d = d1*d_1 + d2*d_2 + d3*d_3 + d4*d_4 + d5*d_5 + d6*d_6;
h = base_haz_d * exp(lin_h);
S = exp(-cum_base_haz_d * exp(lin_h));
* loglik for death;
if (event=1) then loglikD = log(h) + log(S);
if (event=0) then loglikD = log(S);
* loglik for Y;
lin_Y = a1*age + a2*albumin_avg + a3*pre_sbp_avg + a4*nlr_avg
+ a5*post_bmi_avg + a6*male + a7*idwg_percent_avg + a8*ektv_avg
+ a9*vintage +a10*race_white +a11*race_black + eta*v;
*w_T = log(time/700);
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w_T = c0 + c1*dw_1 + c2*dw_2 + c3*dw_3 + c4*dw_4 + c5*dw_5 + c6*dw_6;
mu = exp(w_T + lin_Y);
loglikY = nu*(-hosp_total_days/100/mu-log(mu))
+ nu*log(hosp_total_days/100)+nu*log(nu)-log(gamma(nu));
loglik = loglikD + loglikY;
model time ~ general(loglik);
random v ~ normal(0,sigma2) subject=patient_id out=JM.days22_nu;
ods output ParameterEstimates=JM.days22_est FitStatistics=JM.days22_fit;
run;
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SAS Code Used in Chapter 3
The following SAS code is for the joint modeling of hospitalization and readmission in
Chapter 3:
proc nlmixed data=rehosp.dat_oneyear maxiter=30000 tech=NRRIDG;
bounds sigma2 > 0 ;
parms a0=0.72 a1=0.15 a2=-0.17 a3=-0.14 a4=0.001
a5=-0.03 a6=-0.10 a7=0.24 a8=-0.01 a9=0.19
c1=0.04 c2=-0.13 c3=0.03 c4=-0.007
c5=-0.02 c6=0.05 c7=-0.06 c8=-0.18 c9=0.11;
lambda_lin = exp_yrs_log + a0 + a1*txt + a2*prd + a3*(txt*prd) + a4*age
+ a5*vintage + a6*male + a7*DIABETIC + a8*comorbid_CHF
+ a9*comorbid_COPD + nv;
p_lin = b1*ns_1 + b2*ns_2 + c1*txt + c2*prd + c3*(txt*prd) + c4*age
+ c5*vintage + c6*male + c7*DIABETIC + c8*comorbid_CHF
+ c9*comorbid_COPD+ eta*nv;
loglikY = event_hosp*lambda_lin - exp(lambda_lin);
loglikZ = event_rehosp*p_lin - event_hosp*log(1+exp(p_lin));
loglik = loglikY + loglikZ;
model event_hosp ~ general(loglik);
random nv ~ normal(0,sigma2) subject=patient_id;
ods output ParameterEstimates=rehosp.dat_est FitStatistics=rehosp.dat_fit;
run;
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R Code Used in Chapter 4
The following R code is for the variable selection in Chapter 4:
library(psych)
library(survival)
library(nlme)
# read data for longitudinal covariates
data.Y <- read.table("sample.y.csv", sep=",",header=TRUE)
# read data for survival time
data.T <- read.table("sample.t.csv", sep=",",header=TRUE)
# load initial values generated from marginal models
load("initial.rda")
varnames.fixed <- c("male","diabetic","age")
# main function to perform variable selection
lasso.JM <- function( maxiter=100, rtol=1e-6,
lambda, lambda2, J=5, J1=3){
res.alpha <- res.beta <- res.gamma <- res.gamma0 <- res.sigma.e2
<- res.h0 <- res.Sigma <- res.negPL <- NULL
idRange <- 1:nrow(data.T)
# function to obtain b which maximize kappa(b)
GS <- function() {
b.out <- b
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J <- ncol(b)/2
J1 <- length(alpha)/J
for (id in idRange){
data <- data.Y[data.Y$id==id,]
N <- nrow(data)
X <- data[,colnames(data) %in% varnames.fixed]
time <- data.T[data.T$id==id,]$time
delta <- data.T[data.T$id==id,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
b.est <- rep(0,ncol(b))
kbi.drv <- rep(1,ncol(b))
GS.iter <- 0
while (GS.iter < 10 & sum(kbi.drv^2) > 1e-10) {
b.est.old <- b.est
y.name.ind.all <- data$y.name
alpha.sel.left.all <- J1*(y.name.ind.all-1)+1
beta.sel.all <- 2*y.name.ind.all-1
alpha.matrix <- matrix(rep(0,N*J1),nrow=N)
for (i in 1:N)
alpha.matrix[i,] <- alpha[(alpha.sel.left.all[i]):
(alpha.sel.left.all[i]+J1-1)]
mu <- apply(X*alpha.matrix,1,sum) + beta[beta.sel.all]
+ beta[beta.sel.all+1]*data$y.t + Zi%*%b.est.old
eta <- c(as.numeric(X[1,])%*%gamma0 + t(gamma)%*%b.est.old)
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kbi.drv <- t(data$y-mu)%*%Zi/sigma.e2 + delta*gamma
- h0*time*exp(eta)*gamma - t(b.est.old)%*%solve(Sigma)
Hi <- -t(Zi)%*%Zi/sigma.e2 - c(h0*time*exp(eta))*gamma%*%t(gamma)
- solve(Sigma)
b.est <- b.est.old - solve(Hi)%*%t(kbi.drv)
GS.iter <- GS.iter+1
}
b.out[rownames(b.out)==as.character(id),] <- b.est
}
b.out
}
# negative penalized likelihood
negPL.fun <- function(alpha.est=alpha, beta.est=beta,
gamma0.est=gamma0, gamma.est=gamma,
h0.est=h0, sigma.e2.est=sigma.e2,
Sigma.est=Sigma, b.est=b)
{
PL.neg <- 0
for (id in 1:400) {
data <- data.Y[data.Y$id==id,]
N <- nrow(data)
X <- data[,colnames(data) %in% varnames.fixed]
time <- data.T[data.T$id==id,]$time
delta <- data.T[data.T$id==id,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
mu <- sapply(1:N, function(i)
c(as.numeric(X[i,])%*%alpha.est[(J1*(data$y.name[i]-1)+1)
:(J1*data$y.name[i])]) + beta.est[2*data$y.name[i]-1]
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+ beta.est[2*data$y.name[i]]*data$y.t[i]
+ b.est[rownames(b.est)==as.character(id),
2*data$y.name[i]-1]
+ b.est[rownames(b.est)==as.character(id),
2*data$y.name[i]]*data$y.t[i])
eta <- c(as.numeric(X[1,])%*%gamma0.est)+c(gamma.est
%*%b.est[rownames(b.est)==as.character(id),])
kbi.neg <- N*log(sigma.e2.est)/2
+ c(t(data$y-mu)%*%(data$y-mu)/sigma.e2.est/2)
- delta*log(h0.est) - delta*eta
+ h0.est*time*exp(eta) + log(det(Sigma.est)+0.0000001)/2
+ t(b.est[rownames(b.est)==as.character(id),])%*%
solve(Sigma.est)%*%b.est[rownames(b.est)==as.character(id),]/2
Hi <- -t(Zi)%*%Zi/sigma.e2.est - h0.est*time*exp(eta)*gamma.est
%*%t(gamma.est) - solve(Sigma.est)
PLi.neg <- kbi.neg+log(det(-Hi)+0.00000001)/2
PL.neg <- PL.neg + PLi.neg
}
c(PL.neg) + lambda*sum(abs(gamma.est))*length(idRange) +
lambda2*sum(abs(Sigma.est[upper.tri(Sigma.est)]))*length(idRange)
}
data.X <- data.Y[!duplicated(data.Y$id),]
Z <- NULL
for (id in idRange){
data <- data.Y[data.Y$id==id,]
N <- nrow(data)
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
Z <- rbind(Z, Zi)
}
alpha.hist <- alpha.old <- alpha <- alpha.ini
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beta.hist <- beta.old <- beta <- beta.ini
sigma.e2.hist <- sigma.e2.old <- sigma.e2 <- sigma.e2.ini
Sigma <- Sigma.ini
gamma0.hist <- gamma0.old <- gamma0 <- gamma0.ini
gamma.hist <- gamma.old <- gamma <- gamma.ini
h0.hist <- h0.old <- h0 <- 1
b <- b.ini
negPL.hist <- negPL <- negPL.fun()
k <- 0
rdiff <- 1
scale <- 1/2
maxiter.opt <- 10
# Coordinate Decent Algorithm
while (k < maxiter & rdiff > rtol) {
b <- GS()
alpha.old <- alpha
beta.old <- beta
gamma0.old <- gamma0
gamma.old <- gamma
h0.old <- h0
Sigma.old <- Sigma
sigma.e2.old <- sigma.e2
negPL.old <- negPL
f <- f.new <- negPL.fun()
# update h0
drv1 <- 0
drv1 <- sum(unlist(lapply(idRange, function(id) {
data.Y.row.sel <- data.Y$id==id
data <- data.Y[data.Y.row.sel,]
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N <- nrow(data)
X <- data[,colnames(data) %in% varnames.fixed]
data.T.row.sel <- data.T$id==id
time <- data.T[data.T.row.sel,]$time
delta <- data.T[data.T.row.sel,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
eta <- c(as.numeric(X[1,])%*%gamma0
+ gamma%*%b[rownames(b)==as.character(id),])
H <- -t(Zi)%*%Zi/sigma.e2
- h0*time*exp(eta)*gamma%*%t(gamma) - solve(Sigma)
-tr(solve(H)%*%gamma%*%t(gamma))*h0*time*exp(eta)/2
})))
drv2 <- sum(-data.T$delta/h0 + data.T$time*
exp(as.matrix(data.X[,colnames(data.X)%in%varnames.fixed])
%*%gamma0+b%*%gamma))
drv <- drv1 + drv2
if (drv > 1e-6) {
iter <- 0
step <- 1*0.5^k
h0.update <- h0 - step*drv
while (h0.update < 0) {
step <- scale*step
iter <- iter + 1
h0.update <- h0 - step*drv
}
if (abs(step*drv) >1e-5) {
f.new <- negPL.fun(h0.est = h0.update)
while ( abs(step*drv) >1e-5 & f - f.new < step*drv^2/4) {
step <- scale*step
iter <- iter+1
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h0.update <- h0 - step*drv
f.new <- negPL.fun(h0.est = h0.update)
}
}
h0 <- ifelse(abs(step*drv)<1e-5, h0, h0 - step*drv)
f <- ifelse(abs(step*drv)<1e-5, f, f.new)
}
print(paste("h0",h0,",","iter",iter))
# update gamma
drv2 <- -t(data.T$delta)%*%b + t(h0*data.T$time
*exp(as.matrix(data.X[,colnames(data.X)%in%varnames.fixed])%*%gamma0
+ b%*%gamma))%*%b
for (i in 1:length(gamma)) {
drv1 <- 0
for (id in idRange){
data <- data.Y[data.Y$id==id,]
N <- nrow(data)
X <- data[,colnames(data) %in% varnames.fixed]
time <- data.T[data.T$id==id,]$time
delta <- data.T[data.T$id==id,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
eta <- c(as.numeric(X[1,])%*%gamma0
+ gamma%*%b[rownames(b)==as.character(id),])
H <- -t(Zi)%*%Zi/sigma.e2
- h0*time*exp(eta)*gamma%*%t(gamma) - solve(Sigma)
ind <- numeric(length(gamma))
ind[i] <- 1
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drv1i <- -tr(solve(H)%*%(gamma%*%t(gamma)
*c(b[rownames(b)==as.character(id),i])
+2*ind%*%t(gamma)))*h0*time*exp(eta)/2
drv1 <- drv1 + drv1i
}
drv <- drv1 + drv2[i] + sign(gamma[i])*lambda*length(idRange)
if (abs(drv)>1e-5) {
iter <- 0
step <- 1*0.5^k
gamma.update <- replace(gamma,i,gamma[i]-step*drv)
f.new <- negPL.fun(gamma.est=gamma.update)
while (is.na(f.new)) {
step <- scale*step
iter <- iter + 1
gamma.update <- replace(gamma,i,gamma[i]-step*drv)
f.new <- negPL.fun(gamma.est=gamma.update)
}
while ( abs(step*drv)>1e-5 & f - f.new < step*drv^2/4) {
step <- scale*step
iter <- iter+1
f.new <- negPL.fun(gamma.est=replace(gamma,i,gamma[i]-step*drv))
}
gamma[i] <- ifelse(abs(step*drv)<1e-5, gamma[i], gamma[i]-step*drv)
f <- ifelse(abs(step*drv)<1e-5, f, f.new)
}
print(paste("i",i))
}
print(paste("gamma",gamma,",","iter",iter))
# update alpha
mu <- sapply(1:nrow(data.Y), function(n){
y.name.ind <- data.Y$y.name[n]
alpha.sel <- (J1*(y.name.ind-1)+1):(J1*y.name.ind)
beta.sel <- 2*y.name.ind-1
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b.row.sel <- rownames(b)==as.character(data.Y$id[n])
as.matrix(data.Y[n, colnames(data.Y)%in%varnames.fixed])
%*%alpha[alpha.sel] + beta[beta.sel] + beta[beta.sel+1]
*data.Y$y.t[n] + b[b.row.sel,beta.sel]
+ b[b.row.sel,beta.sel+1]*data.Y$y.t[n]
} )
if (sum(abs(data.Y$y-mu)) > 1e-6) {
for (idx1 in 1:(length(alpha))) {
x.idx1 <- ifelse(idx1%%J1==0, J1, idx1%%J1)
y.idx1 <- (idx1-x.idx1)/J1+1
iter <- 0
data.tmp <- data.Y[data.Y$y.name==y.idx1,]
drvdrv <- sum(data.Y[data.Y$y.name==y.idx1,
colnames(data.tmp)==varnames.fixed[x.idx1]]^2)/sigma.e2
alpha.est <- alpha
drv <- 1
while (iter < 10 & sum(drv^2) > 1e-10) {
mu <- sapply(1:nrow(data.tmp), function(n){
y.name.ind <- data.tmp$y.name[n]
alpha.sel <- (J1*(y.name.ind-1)+1):(J1*y.name.ind)
beta.sel <- 2*y.name.ind-1
b.row.sel <- rownames(b)==as.character(data.tmp$id[n])
as.matrix(data.tmp[n,colnames(data.Y)%in%varnames.fixed])
%*%alpha.est[alpha.sel] + beta[beta.sel] + beta[beta.sel+1]
*data.tmp$y.t[n] + b[b.row.sel,beta.sel]
+ b[b.row.sel,beta.sel+1]*data.tmp$y.t[n]
} )
drv <- -sum(((data.tmp$y-mu)*as.matrix(data.tmp[,
colnames(data.tmp)==varnames.fixed[x.idx1]])))/sigma.e2
alpha.est.old <- alpha.est
alpha.est[idx1] <- alpha.est.old[idx1] - drv/drvdrv
iter <- iter+1
}
alpha <- alpha.est
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}
}
print(paste("alpha",alpha,",","iter",iter))
# update beta
iter <- 0
mu <- sapply(1:nrow(data.Y), function(n){
y.name.ind <- data.Y$y.name[n]
alpha.sel <- (J1*(y.name.ind-1)+1):(J1*y.name.ind)
beta.sel <- 2*y.name.ind-1
b.row.sel <- rownames(b)==as.character(data.Y$id[n])
as.matrix(data.Y[n,colnames(data.Y)%in%varnames.fixed])
%*%alpha[alpha.sel] + beta[beta.sel] + beta[beta.sel+1]
*data.Y$y.t[n] + b[b.row.sel,beta.sel]
+ b[b.row.sel,beta.sel+1]*data.Y$y.t[n]
} )
drv <- -t(as.matrix(data.Y$y-mu))%*%Z/sigma.e2
H <- t(Z)%*%Z/sigma.e2
beta.est <- beta
while (iter < 10 & sum(abs(drv)) > 1e-6) {
mu <- sapply(1:nrow(data.Y), function(n){
y.name.ind <- data.Y$y.name[n]
alpha.sel <- (J1*(y.name.ind-1)+1):(J1*y.name.ind)
beta.sel <- 2*y.name.ind-1
b.row.sel <- rownames(b)==as.character(data.Y$id[n])
as.matrix(data.Y[n,colnames(data.Y)%in%varnames.fixed])
%*%alpha[alpha.sel] + beta.est[beta.sel] + beta.est[beta.sel+1]
*data.Y$y.t[n] + b[b.row.sel,beta.sel]
+ b[b.row.sel,beta.sel+1]*data.Y$y.t[n]
} )
drv <- -t(data.Y$y-mu)%*%Z/sigma.e2
beta.est.old <- beta.est
beta.est <- beta.est.old - solve(H)%*%t(drv)
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iter <- iter+1
}
print(paste("beta",beta,",","iter",iter))
# update sigma.e2
iter <- 0
drv1 <- sum(unlist(lapply(idRange, function(id) {
data.Y.row.sel <- data.Y$id==id
data <- data.Y[data.Y.row.sel,]
N <- nrow(data)
X <- as.matrix(data[,colnames(data)%in%varnames.fixed])
data.T.row.sel <- data.T$id==id
time <- data.T[data.T.row.sel,]$time
delta <- data.T[data.T.row.sel,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
eta <- c(as.numeric(X[1,])%*%gamma0
+ gamma%*%b[rownames(b)==as.character(id),])
H <- -t(Zi)%*%Zi/sigma.e2
- h0*time*exp(eta)*gamma%*%t(gamma) - solve(Sigma)
drv1i <- tr(solve(H)%*%t(Zi)%*%Zi)/(sigma.e2^2)/2
drv1i
})))
mu <- sapply(1:nrow(data.Y), function(n){
y.name.ind <- data.Y$y.name[n]
alpha.sel <- (J1*(y.name.ind-1)+1):(J1*y.name.ind)
beta.sel <- 2*y.name.ind-1
b.row.sel <- rownames(b)==as.character(data.Y$id[n])
as.numeric(data.Y[n,colnames(data.Y)%in%varnames.fixed])
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%*%alpha[alpha.sel] + beta[beta.sel]
+ beta[beta.sel+1]*data.Y$y.t[n] + b[b.row.sel,beta.sel]
+ b[b.row.sel,beta.sel+1]*data.Y$y.t[n]
})
drv2 <- nrow(data.Y)*1/sigma.e2/2
- c(t(data.Y$y-mu)%*%(data.Y$y-mu)/(sigma.e2^2*2))
drv <- drv1 + drv2
if (sum(abs(drv)) > 1e-5) {
if (f - negPL.fun(sigma.e2.est = sigma.e2-sign(drv)*1e-5)
> (1e-5)^2/4)
{
iter <- 0
step <- 0.01*0.5^k
sigma.e2.update <- sigma.e2 - step*drv
while (sigma.e2.update < 0) {
step <- scale*step
iter <- iter + 1
sigma.e2.update <- sigma.e2 - step*drv
}
if (abs(step*drv) >1e-5) {
f.new <- negPL.fun(sigma.e2.est=sigma.e2.update)
while ( abs(step*drv) >1e-5 & f - f.new < step*drv^2/4) {
step <- scale*step
iter <- iter+1
sigma.e2.update <- sigma.e2 - step*drv
f.new <- negPL.fun(sigma.e2.est = sigma.e2.update)
}
}
sigma.e2 <- ifelse(abs(step*drv)<1e-5, sigma.e2, sigma.e2.update)
f <- ifelse(abs(step*drv)<1e-5, f, f.new)
}
}
print(paste("sigma.e2",sigma.e2,",","iter",iter))
# update gamma0
drv1 <- rep(0,length(gamma0))
drv1.list <- lapply(idRange, function(id){
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data <- data.Y[data.Y$id==id,]
N <- nrow(data)
X <- as.matrix(data[,colnames(data)%in%varnames.fixed])
time <- data.T[data.T$id==id,]$time
delta <- data.T[data.T$id==id,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
for (j in 2:J) {
t <- data[data$y.name==j,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
eta <- c(as.numeric(X[1,])%*%gamma0
+ gamma%*%b[rownames(b)==as.character(id),])
H <- -t(Zi)%*%Zi/sigma.e2
- h0*time*exp(eta)*gamma%*%t(gamma) - solve(Sigma)
drv1i <- -tr(solve(H)%*%gamma%*%t(gamma))*h0*time*exp(eta)*X[1,]/2
drv1i
})
drv1 <- apply(matrix(unlist(drv1.list),
nrow=length(gamma0), byrow=TRUE), 1, sum)
drv2 <- -t(data.T$delta)%*%
as.matrix(data.X[,colnames(data.X)%in%varnames.fixed]) + t(h0
*data.T$time*exp(as.matrix(data.X[,colnames(data.X)%in%varnames.fixed])
%*%gamma0+b%*%gamma))%*%
as.matrix(data.X[,colnames(data.X)%in%varnames.fixed])
drv <- drv1 + drv2
for (i in 1:length(gamma0)) {
if (abs(drv[i]) > 1e-5) {
iter <- 0
if (f - negPL.fun(gamma0.est = replace(gamma0,
i,gamma0[i]-sign(drv[i])*1e-5)) > (1e-5)^2/4)
{
step <- 0.01*0.5^k
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while ( abs(step*drv[i])>1e-5 & f - f.new < step*drv[i]^2/4){
step <- scale*step
iter <- iter+1
f.new <- negPL.fun(gamma0.est = replace(gamma0,
i,gamma0[i]-step*drv[i]))
}
gamma0[i] <- ifelse(abs(step*drv[i])<1e-5,
gamma0[i], gamma0[i] - step*drv[i])
f <- ifelse(abs(step*drv[i])<1e-5, f, f.new)
}
}
print(paste("i",i))
}
print(paste("gamma0",gamma0,",","iter",iter))
# update Sigma
system.time({
iter <- 0
for (i in 1:ncol(b)) {
for (j in 1:i){
Sigma.inv <- solve(Sigma)
Sigma.drv <- matrix(numeric(ncol(b)*ncol(b)), ncol=ncol(b))
Sigma.drv[i,j] <- Sigma.drv[j,i] <- 1
drv <- sum(unlist(lapply(idRange, function(id){
data.Y.row.sel <- data.Y$id==id
data <- data.Y[data.Y.row.sel,]
N <- nrow(data)
X <- as.matrix(data[,colnames(data)%in%varnames.fixed])
data.T.row.sel <- data.T$id==id
time <- data.T[data.T.row.sel,]$time
delta <- data.T[data.T.row.sel,]$delta
t <- data[data$y.name==1,]$y.t
n <- length(t)
Zi <- matrix(c(rep(1,n),t),n,2)
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for (jj in 2:J) {
t <- data[data$y.name==jj,]$y.t
n <- length(t)
z <- matrix(c(rep(1,n),t),n,2)
Zi <- superMatrix(list(Zi,z))
}
eta <- c(as.numeric(X[1,])%*%gamma0
+ gamma%*%b[rownames(b)==as.character(id),])
H <- -t(Zi)%*%Zi/sigma.e2
- h0*time*exp(eta)*gamma%*%t(gamma) - Sigma.inv
drv1i <- tr(Sigma.inv%*%Sigma.drv)/2 -
t(b[rownames(b)==as.character(id),])%*%Sigma.inv%*%Sigma.drv
%*%Sigma.inv%*%b[rownames(b)==as.character(id),]/2
drv2i <- tr(solve(H)%*%Sigma.inv%*%Sigma.drv%*%Sigma.inv)/2
drv1i + drv2i
})))
drv <- drv
+ (i!=j)*lambda2*sign(Sigma[i,j])*length(idRange)*abs(Sigma[i,j])
if (abs(drv) > 1e-5) {
if (f - negPL.fun(Sigma.est = replace(Sigma,
c((j-1)*ncol(b)+i,(i-1)*ncol(b)+j),Sigma[i,j]-sign(drv)*1e-5))
> (1e-5)^2/4)
{
iter <- 0
step <- 0.01*0.5^k
if (abs(step*drv) > 1e-5 ) {
Sigma.update <- replace(Sigma,
c((j-1)*ncol(b)+i,(i-1)*ncol(b)+j),Sigma[i,j]-step*drv)
while (det(Sigma.update) < 0) {
step <- scale*step
iter <- iter + 1
Sigma.update <- replace(Sigma,
c((j-1)*ncol(b)+i,(i-1)*ncol(b)+j),Sigma[i,j]-step*drv)
}
f.new <- negPL.fun(Sigma.est = Sigma.update)
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while ( abs(step*drv) > 1e-5 & f - f.new < step*drv^2/4) {
step <- scale*step
iter <- iter+1
Sigma.update <- replace(Sigma,
c((j-1)*ncol(b)+i,(i-1)*ncol(b)+j),Sigma[i,j]-step*drv)
f.new <- negPL.fun(Sigma.est = Sigma.update)
}
}
Sigma[i,j] <- Sigma[j,i] <-
ifelse(abs(step*drv) < 1e-5, Sigma[i,j], Sigma[i,j]-step*drv)
f <- ifelse(abs(step*drv)<1e-5, f, f.new)
}
}
print(paste("i",i,"j",j))
}
}
print(Sigma)})
negPL <- f
rdiff <- c(abs(negPL - negPL.old)/(abs(negPL.old)+0.000001))
k <- k+1
print(paste("rdiff",rdiff,",","iter",k-1))
print(list(alpha=alpha, beta=beta, gamma=gamma, gamma0=gamma0,
Sigma=Sigma, sigma.e2=sigma.e2, h0=h0, negPL=negPL,
rdiff=rdiff, iter=k))
}
list(alpha=alpha, beta=beta, gamma=gamma, gamma0=gamma0,
Sigma=Sigma, sigma.e2=sigma.e2, h0=h0, negPL=negPL,
rdiff=rdiff, iter=k)
}
lasso.JM(lambda=0.005, lambda2=0.1)
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